Antimicrobial activity of essential oils as liquid and vapour applications by Elcocks, Ellena Rae
  
 
 
 
 
 
ANTIMICROBIAL ACTIVITY OF ESSENTIAL OILS AS LIQUID AND VAPOUR 
APPLICATIONS 
 
ELLENA RAE ELCOCKS 
 
 
A thesis submitted in partial fulfilment of the requirements of the University of 
the West of England, Bristol for the degree of Doctor of Philosophy (PhD) 
 
 
Faculty of Applied Sciences, University of the West of England, Bristol 
December 2019 
 
Word Count: 32,613 
 
 
ii 
ABSTRACT 
 
Essential oils produced by plants have been used as antimicrobial agents 
historically, however, many essential oils remain under-exploited as 
alternatives to current antimicrobials. Therefore, the aim of this thesis was to 
evaluate the antibacterial efficacy of selected essential oils against bacteria 
which have the ability to form biofilms. The broad-spectrum activity of several 
essential oils is demonstrated, with subsequent focus on the strong 
antimicrobial activity of cinnamon essential oil extracted from Cinnamomum 
zeylanicum bark. Cinnamon bark essential oil showed broad spectrum activity 
against a range of bacteria, some of which are relevant clinically, including 
Pseudomonas aeruginosa which is capable of forming biofilms and implicated 
in many human diseases. Cinnamon bark essential oil killed planktonic P. 
aeruginosa at concentrations as low as 0.125% (v/v), and within 2 min when 
at concentrations of ≥1% (v/v). It also exhibited anti-biofilm activity, in both 
liquid and vapour form, against P. aeruginosa biofilms grown using a Centre 
for Disease Control biofilm reactor on polycarbonate and stainless steel 
surfaces. Liquid application of 2% (v/v) resulted in biofilm eradication in as little 
as 10 min. When assessed in a novel testing chamber, designed and built as 
part of this project, cinnamon EO reduced biofilms at vapour concentrations 
as low as 0.2 µL cm-3. These results provide clear evidence for the potential 
of cinnamon bark essential to be considered as a novel antimicrobial, and to 
contribute to the improvement of hygiene and sanitation. As well as addressing 
the global issue of antibiotic resistance, data presented also provide evidence 
for the ability of essential oils to inhibit and eradicate biofilms, which increases 
tolerance of pathogenic bacteria to antimicrobials. Data presented here 
provide the basis of additional work to investigate development of disinfectant 
products, evaluate essential oil toxicity, and further study the role of essential 
oils in combatting antimicrobial resistance. 
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CHAPTER 1 
 
3 
1 INTRODUCTION  
1.1 Antimicrobial resistance (AMR) 
1.1.1 Origin and impact 
In 1929, Sir Alexander Fleming demonstrated the potential antimicrobial use 
of penicillin. In 1943, penicillin was introduced for therapeutic use (Ventola 
2015) and by the late 1940s, many antibiotics became commercially available, 
becoming crucial in combating previously untreatable infections and diseases 
(Debabov 2013). However, Fleming proposed that inappropriate use of 
penicillin might cause Staphylococcus aureus to mutate, leading to more 
severe infections and the transmission of these resistant strains from host to 
host, thus predicting AMR (Rosenblatt-Farrell 2009). Even before the 
introduction of penicillin in 1943, in 1940, resistance to this drug was already 
demonstrated (Ventola 2015). Thus, in agreement with the evidence, and true 
to Fleming’s warnings, within one year of widespread use, substantial numbers 
of staphylococcal strains were exhibiting resistance to penicillin (Lobanovska 
and Pilla 2017). A few years later, over 50% of S. aureus species were no 
longer susceptible (Alanis 2005).  
 
Approximately 100,000 tons of antibiotics are produced globally per year 
(Martens and Demain 2017), and for every 10 min passed, 2 tonnes of 
antibiotics are used (Harbarth et al. 2015). Not only have bacteria developed 
resistance but many strains have become resistant to multiple antibiotics and 
chemotherapeutic agents, termed multi-drug resistance (MDR; Nikaido 2009). 
MDR can be defined as non-susceptibility to at least one agent, in three or 
more antimicrobial categories (Magiorakos et al. 2012). The Centre for 
4 
Disease Control and Prevention (CDC) categorises MDR bacteria into one of 
three threat levels: urgent, serious or concerning (Figure 1.1; CDC 2018).  
 
Of these organisms, the ESKAPE pathogens (Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) are reported to 
be the leading cause of nosocomial infections throughout the world (Santajit 
and Indrawattana 2016). The global threat of MDR bacteria has raised the 
need for urgent therapeutic discoveries, improvement of existing infection 
control, and development of antimicrobial practices. Microorganisms, more 
than ever before, are able to combat antimicrobial drugs, leading to 
unsuccessful management, perseverance and infection spread (Tanwar et al. 
 
 
Figure 1.1 – Organism Threat Levels. 
Classification of organisms by threat level as outlined by the Centre of Disease 
Control (2018). Image created by author using data from CDC (2018). 
5 
2014). Within the EU, MDR infections are responsible for approximately 
25,000 patient deaths per year, with over 63,000 patient deaths per year in the 
United States caused by hospital-acquired bacterial infections (Aminov 2010). 
MDR bacterial infections result in extra healthcare costs and productivity 
losses costing the EU at least 1.5 billion euros each year (Department of 
Health 2016). Deaths attributable to AMR are expected to reach 10 million per 
year by 2050, which would overtake cancer as the leading cause of death 
(O’Neill 2014). 
 
1.1.2 Drivers of resistance 
One of the biggest drivers of AMR is the overuse and abuse of antibiotics. 
Their abundant consumption since introduction and inappropriate distribution 
has played a massive role in AMR (Ventola 2015). The substantial use of 
antibiotics in agriculture and aquaculture, for growth promotion and reduction 
of disease, (Prestinaci et al. 2015), and the lack of funding and budgets within 
healthcare for new effective antibiotics to be available commercially (Levy and 
Bonnie 2004), also contribute to AMR. However, though antibiotic misuse is a 
primary driver for AMR, it is not the only culprit. Biocides, metals and naturally 
occurring resistance genetics all play a role in increased AMR (Singer et al. 
2016). Biocides such as ethanol, formaldehyde, chlorhexidine, 
triclosan, and quaternary ammonium compounds, and metals which originate 
from drainage water, household effluent and traffic related emissions both 
contribute to the co-selection of genes that promote resistance (Singer et al. 
2016). Resistance transmission routes are distributed throughout our 
6 
everyday life (Figure 1.2) and it is important to address each root cause in order 
to combat AMR.  
 
 
1.1.2.1 Inappropriate prescribing and misuse  
Amongst the European countries, the UK is in the lower half with regards to 
outpatient antibiotic use (Smieszek et al. 2018). Despite this, it is estimated 
that 20% of antibiotics prescribed are done so unnecessarily (Courtenay et al. 
2019). Problems arise when doctors have an inaccurate diagnosis and 
prescribe antibiotics as a precaution, or a broad spectrum drug is used. A 
 
Figure 1.2 – Potential routes of transmission of resistant bacteria.  
Antibiotics used in agriculture and farming transmit resistant bacteria to both 
humans and aquatics via food and water run-off. Waste water systems transmit 
to aquatics and wildlife, which in turn may transmit to domestic animals and 
humans. Bacteria which are resistant to antibiotics used in hospital environments 
transmit to the population. (Image reproduced from Harbarth et al. 2015; CC BY 
4.0)    
7 
recent report by Public Health England revealed that the majority of 
prescriptions given for antibiotics were for respiratory or urinary tract 
infections, although nearly a third of these gave no clinical reasoning (Public 
Health England 2018). Results of the report revealed the staggering 
differences between drugs being prescribed versus the ideal number of cases 
where prescription is necessary (Table 1.1), thus highlighting the opportunity 
for practices across the country to reduce their prescribing rates.  
 
Patient compliance is another factor to consider when discussing misuse of 
antibiotics. Patients may discontinue treatment when they feel that their health 
has returned, though one of the biggest reasons for non-compliance is patient 
fear of side-effects caused by extended use of the drugs (Tong et al. 2018). 
Withdrawing from treatment, before the course of antibiotics has been 
completed, exposes organisms to sub-lethal concentrations of drugs and 
leads to acquired resistance (Niederman 2005).  
Table 1.1 – Prescription Rates. 
Public Health England (2018) evaluation of rates of antibiotic 
prescriptions compared to their ideal prescribing rate. 
Infection 
Percentage of patients 
prescribed antibiotics (%) 
Actual Ideal 
Uncomplicated acute 
cough 
41 10 
Bronchitis 82 13 
Sore throat 59 13 
Rhinosinusitis 88 11 
Acute otitis media 
(children/young adults) 
92 17 
 
8 
Another recognised factor to consider is the lack of regulatory and legislative 
controls in many countries, which would normally govern the distribution of 
antimicrobials (Michael et al. 2014). In developing countries, where healthcare 
is not provided universally, antibiotics are often uncontrolled, with regulatory 
guidelines varying from country to country  (Zaman et al. 2017). Self-
medicating with antibiotics is a regular occurrence in developing countries 
where prescriptions are not necessary and supply chains are not controlled 
(Ayukekbong et al. 2017) 
 
1.1.2.2 Extensive agricultural use 
The majority of antimicrobials used in agriculture are similar, if not identical, to 
those used clinically in the human population, and the food-chain is reported 
to be the primary route of transmission of AMR organisms (Zaman et al. 2017). 
Antibiotics used at sub-lethal doses are used in agriculture, farming, fisheries 
and crops to treat infections, prevent disease and promote growth. In animals 
this leads to gut microflora developing high resistance and becoming a 
reservoir of AMR organisms (Gupta and Deka 2018). Although the use of 
growth promoter antibiotics has been banned in Europe since 2006 (Prestinaci 
et al. 2015), the US are only more recently following suit. In contrast to this, 
places like China, India, Pakistan and Egypt, are showing an inflation in 
antibiotic use in animals (Anomaly 2019).  
 
1.1.2.3 Availability of few new antimicrobials 
Bacteria have historically become resistant to bacteria within ~5 years of a 
new antibiotic being introduced and/or used (Figure 1.3). This quick turnover 
9 
of new antibiotics has been detrimental to our repertoire of effective drugs. 
This, in combination with the lack of novel antimicrobials reaching end stage, 
often due to a lack of funding or incentive, is another driver of resistance. The 
sheer nature of antibiotic consumption, which is usually a short-course 
treatment, is not usually motivation for drug companies to develop these drugs 
which will not bring them much revenue in the long term (Gould and Bal 2013). 
Furthermore, many of the drugs used are mass produced at low prices, 
therefore many drug companies are apprehensive to invest in new drugs as 
they fear they will incur million dollar losses (Ventola 2015). The Food and 
Drug Administration (FDA) have regulatory strategies in place, aimed at fast-
tracking the development of novel antimicrobials in their later stages of 
research, though these often overlook the smaller companies who lack the 
funds to reach the later stages of research required to benefit (Simpkin et al. 
2017). 
10 
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1.1.3 Bacterial mechanisms of resistance 
Resistance relies on two factors: the antimicrobial which is effective against 
susceptible organisms and selects resistant ones; and the resistance 
mechanisms present in the organism selected by the drug (Levy and Bonnie 
2004). Resistance emerges when these two factors come together. There are 
many described mechanisms of resistance, and unfortunately no antibiotic has 
avoided one (Bonomo and Rossolini 2008). The basis of AMR can be 
simplified to fall into two categories: genetic or mechanistic (Munita and Arias 
2016), but often these two categories overlap and/or influence each other. 
Genetic resistance can be intrinsic or acquired. Intrinsic mechanisms are 
already present in the genetic composition of bacteria, whereas acquired 
resistance is usually obtained by horizontal gene transfer via plasmids, 
bacteriophage, naked DNA, transposons or integrons (Levy and Bonnie 2004, 
Peterson and Kaur 2018). Intrinsic mechanisms include generic efflux pumps 
capable of pumping antimicrobials out of the cell, inactivation enzymes 
capable of incapacitating the drug, and permeability barriers that will prevent 
the penetration of drugs (Fajardo et al. 2008, Blair et al. 2015). Acquired 
mechanisms include plasmid encoded efflux and enzymes for modification of 
drugs (Peterson and Kaur 2018). Bacteria can also use alternative metabolic 
pathways to those targeted by the drug (Tenover 2006), can prevent binding 
of drugs via target modification (Miller 2016), or over-express the target 
enzyme to negate the inhibitory effects of the antibiotic (Palmer and Kishony 
2014). Another bacterial mechanism of resistance that should be considered 
is the ability to form a biofilm, and its resistance can be attributed to physical, 
physiological and genetic mechanisms (Ciofu and Tolker-Nielsen 2019).  
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1.1.4 Biofilms 
It was once believed that bacteria only acted singularly in a planktonic state, 
but it is now understood that this is not the case. Biofilms are dense 
populations of bacteria, which are irreversibly attached to a surface, and 
protected by a robust exopolymeric matrix. Biofilm formation is often thought 
to be the primary underlying cause for the failure of an antimicrobial agent, 
with 65-80% of all infections believed to be biofilm-related (Coenye and Nelis 
2010). Cells existing as a biofilm often have an increased resistance to 
microbial agents of up to 10–1000 times (Mah and O’Toole 2001). 
Bacteria instigate biofilm formation and communicate via quorum sensing 
(Gerdt and Blackwell 2014). It is described as an intercellular chemical 
signalling mechanism that is used by bacteria to monitor cell population and 
density. Biofilms are cell density dependent and require sufficient quantities to 
induce QS signal accumulation and thus QS gene expression. Many of these 
genes activated by QS are group beneficial and aid in the secretion of 
proteases, siderophores and toxins (Gerdt and Blackwell 2014).  
 
1.1.5 Biofilm formation  
The formation and survival of biofilms can be broken down into several steps, 
usually attachment, growth, maturation and detachment (Figure 1.4; O’Toole 
2003). Initial attachment relies on many factors for success, growth and 
maturation. Biofilms need a continued supply of nutrients, flow of waste and 
efficient communication within the biofilm, and effective survival requires the 
detachment of cells to begin the cycle again. Furthermore, naturally occurring 
biofilms will often consist of a mixed-species arrangement (Kommerein et al. 
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2018). This interspecies arrangement involves communication (QS), 
metabolic cooperation, and interactions can be competitive or synergistic 
(Elias and Banin 2012). 
 
 
1.1.5.1 Attachment  
Initial attachment relies on a surface, which would ideally be hydrophobic with 
nano or micro-scale roughness, and triggers physiochemical bacterial surface 
detection factors which administrate adherence (Cortés et al. 2011). Almost 
all natural surfaces have an overall negative charge, which primarily acts 
 
Figure 1.4 – Stages of Biofilm Growth. 
Diagram showing an overview of biofilm formation. Formation begins with 
reversible attachment (1), followed by irreversible attachment, cell division 
and EPS excretion (2). A secondary bacterial species may be introduced as 
the biofilm matures (3), before critical mass is reached, and cells are 
released (4). Image created by author.  
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repulsively towards the electrostatic charges in bacterial adhesion, thus 
adherence must overcome this using attractive Lifshitz-van der Waals, Lewis 
acid-base, hydrophobic, and other specific interaction forces (Van Merode et 
al. 2006). Bacteria can be transported to a surface via Brownian motion, 
specific gravity sedimentation or convective transport in a bulk fluid (Palmer et 
al. 2007). Initial formation begins with polar attachment of planktonic bacteria 
which at this stage is reversible, followed by movement of cells to align 
themselves flat to the surface and resist attempts of removal (Armbruster and 
Parsek 2018). In cases where bacteria possess flagella for motility, repression 
of the flagellum is often initiated after attachment, mediated by the cytoplasmic 
signalling molecule cyclic diguanylate, and supporting the formation of a non-
motile aggregation of cells (Guttenplan and Kearns 2013). Irreversible cell 
attachment involves robust cell to cell organisation with binding proteins, 
hydrolysation of cell adhesion molecules by enzymes and protein adsorption 
(Pavithra and Doble 2008). Furthermore, all of the above mentioned processes 
are influenced by flow, carbon and oxygen levels, pH, nutrient availability and 
temperature (O’Toole et al. 2000, Toyofuku et al. 2016). Once bacteria have 
overcome this process of biofilm formation, growth and maturation can begin.  
 
1.1.5.2 Growth and maturation 
Increased quorum sensing, development of micro-colonies and the formation 
of extracellular polymeric covering mark the beginnings of biofilm growth, 
which eventually leads to a 3-dimensional structure of cell clusters (Toyofuku 
et al. 2016, Arunasri and Mohan 2019). Cells in micro-colonies begin to 
actively replicate by cell division (Toyofuku et al. 2016), generating 
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extracellular components which form a glycoprotein and glycolipid covering, 
following interaction with organic and inorganic materials surrounding them 
(Dunne 2002). The polymer matrix, or exopolysaccharide matrix (EPS), can 
be described as a gel like substance with high water content, which protects 
microbial cells from desiccation, among other purposes (Carpentier 1993). 
EPS are biopolymers consisting of polysaccharides, proteins, glycoproteins, 
glycolipids and extracellular DNA (Flemming et al. 2007); it has channels that 
facilitate the transportation of water, nutrients and removal of waste (Arunasri 
and Mohan 2019); and its quantity varies throughout maturation, often 
doubling in mass when reaching maturation (Jiao et al. 2010), but is also 
dependent on environmental factors and the strain of bacteria forming the 
biofilm (Harmsen et al. 2010). The structure of a mature biofilm largely 
depends on location, constituent organisms and nutrient concentration, and its 
structure can represent a homogeneous layer, dispersed micro-colonies, or 
protruding cell clusters (Reisner et al. 2003).  
When a high density of cells is reached, chemical signals which are recognised 
by receptors within the same cells, known as autoinducers, are released. 
These chemical signals were originally thought to be released as 
siderophores, antibiotics, or as waste products (Hense and Schuster 2015). 
Acyl-homoserine lactones (AHLs), oligopeptide autoinducers, and autoinducer 
2 (AI-2; furanosyl borate diester) are all recognised autoinducer molecules that 
have been found in bacteria (Hense and Schuster 2015). When the level of 
autoinducers reaches a critical level, bacteria respond with repression or 
expression of target genes (Wolska et al. 2016). Gene expression can benefit 
the biofilm by increasing virulence, promoting genetic transfer, upregulating 
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biofilm EPS production, upregulating efflux pumps, and contributing to 
resistance to stressors (Cortés et al. 2011, Butt and Khan 2015, Subhadra et 
al. 2016). Once maturation is reached, cells become inactive and die due to 
lack of nutrients, pH fluctuations, oxygen deprivation or poisoning by toxic 
accumulations of waste (Dunne 2002). At this point, biofilms will initiate a 
detachment and dispersal process to support survival.   
 
1.1.5.3 Detachment and dispersal 
Dispersal of a biofilm can occur after a number of processes take place. Cells 
could cease synthesis of biofilm matrix compounds, active degradation of the 
matrix could occur, or disruption of covalent bonds between matrix 
components could all accomplish detachment and dispersal (Solano et al. 
2014). Bacteria may leave a biofilm by either desorption, detachment or 
dispersion, which are all classified as methods of “escape” (Davies 2011). 
These mechanisms can also be classified into active or passive, where active 
escape is initiated by the bacteria and passive escape is determined by 
external forces such as collision forces, predation, fluid shear, and human 
intervention (Kaplan 2010), formally known as abrasion, grazing, erosion, and 
sloughing, respectively (Petrova et al. 2016). Active escape mechanisms are 
usually induced by the selection pressures experienced by bacteria and the 
inane strategy for survival (Davies 2011). Once the biofilm has reached a 
critical mass, the outermost layer experiences dynamic equilibrium and 
planktonic cells are generated (Dunne 2002). The release of cells from the 
margins and outermost layers of a biofilm is the more commonly observed 
method of escape detachment, although cells may escape from the interior of 
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the biofilm which is known as dispersion (Davies 2011). The cells released can 
move freely, colonise surfaces and begin the cycle over again (Dunne 2002).   
 
1.1.6 Biofilm tolerance 
Biofilm tolerance to antimicrobials can be explained primarily by the failure of 
the antimicrobial agent to penetrate the biofilm, largely due to the presence of 
an EPS layer that is secreted when the biofilm is maturing (Butt and Khan 
2015). This EPS acts as a preliminary barrier that will delay or completely 
prevent penetration by antimicrobial agents, although studies have indicated 
that this feature is often not alone in preventing infiltration (Mah and O’Toole 
2001). Another cause is the slow growth rate. When biofilms are forming there 
is inevitably nutritional limitation and this stressor causes biofilms to exhibit a 
slower growth rate, which has been connected to an increased resistance as 
the bacteria approach stationary phase (Evans et al. 1991). Wentland et al. 
(1996) implemented a staining technique that was used to visualise the 
different growth rates within a bacterial biofilm and found that slow growth was 
apparent within the denser sections of biofilm, and bacteria exposed to the 
bulk medium showed faster growth rate. Williamson et al. (2012) concluded 
that cells deepest within a thick biofilm were in a viable, but antibiotic-tolerant, 
slow growing state. The general stress response can also be a significant 
indicator of increased resistance when in a biofilm. Stressors induce many 
physiological changes which act to protect the cell from starvation, osmolarity 
changes, pH shifts, heat shock or DNA damage (Hengge 2014).  
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1.2 Combatting AMR & current status  
Directly addressing the drivers of resistance, as mentioned before, are the 
steps necessary to combatting AMR. Improving education and knowledge on 
AMR, global interventions to reduce the overuse and misuse of the antibiotics 
we have, and investments and support to boost the search for novel or 
alternative antimicrobials are just a few ways we can combat the crisis. Some 
countries sought to combat the threat of AMR as early as the 1990s (Harbarth 
et al. 2015), but it is not until more recently that other countries have joined 
suit. The UK has had anti-AMR strategies in place since 2000 (Mayor 2019). 
In 2014, David Cameron, Prime Minister of the United Kingdom, enlisted the 
help of economics expert Jim O’Neill to evaluate the AMR situation (O’Neill 
2014). In 2016, Barack Obama, president of the United States, nearly doubled 
the US funding for combatting and preventing AMR, pledging to invest $1.2 
billion (Obama White House 2015). The report put forward by Jim O’Neill 
indicates 10 interventions that need to be carried out without delay, in order to 
combat AMR. These 10 steps include: increasing global awareness of AMR 
using campaigns and programmes; improving hygiene and sanitation to 
prevent infection spread; reduce the use of antimicrobials in agriculture; 
improve surveillance of resistance and antimicrobial consumption; renew 
efforts to search for rapid diagnostic technology; use vaccines and alternatives 
to antibiotics; improve incentives for working in the field of infectious diseases; 
increased funding for non-commercial research; promote investments into 
new drugs and improve existing ones; and generate a global alliance in 
combatting AMR. In 2019, the UK published its most recent 5 year strategy to 
combat AMR (HM Government 2019). Data from the previous 5 year plan, 
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spanning 2013-2018, demonstrate a 7% decrease in human antibiotic 
consumption and a 40% decrease in sales of antibiotics for agriculture. 
Despite the reduction in antibiotic sales, blood stream infections caused by 
resistant organisms increased 35% over the 2013-2018 time frame (Courtenay 
et al. 2019). The work within this thesis will primarily focus on the search for 
alternative antimicrobials, specifically in those that are effective against 
biofilms. Potential options for novel antimicrobials include the use of natural 
compounds such as those derived from plants (essential oils, phenolics, 
lectins and polyacetylenes), animals (lactoferrin, chitosan and lysozymes), 
bacteria (bacteriocin, reuterin), algae, and fungi (Cowan 1999, Gyawali and 
Ibrahim 2014). Alternatives may also include prebiotics and probiotics, drugs 
that target communication within bacterial communities, or antibody based 
drugs (Harbarth et al. 2015). Recent approaches include exploring peptide 
based antibiotics (Roshan et al. 2018), renewing phage-therapy based 
techniques (Kortright et al. 2019), employing metal, polymeric and lipid based 
nanoparticles as antimicrobials (Lakshminarayanan et al. 2018), developing 
nanohybrid combinations of silica and antibiotics (Mosselhy et al. 2018), and 
the sequencing of prokaryote genomes to discover novel antimicrobial 
molecules (Tracanna et al. 2017). Bacterial biofilms can be combatted with 
several different aims in mind: prevent initial contamination; minimise initial 
attachment; or penetrate the preformed biofilms and eradicate the associated 
cells (Donlan 2002). 
The research put forward in this thesis will also contribute to several aspects 
of the 10 interventions outlined by O’Neill (2016). It will address the need for 
novel antimicrobials, contributing to the improvement of hygiene and 
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sanitation, and potentially improve existing antimicrobials. It will do this by 
exploring essential oils as a novel antimicrobial that could contribute to 
combatting AMR.  
 
1.2.1 Essential oils 
Essential oils (EOs) are naturally occurring products of plants, which can be 
extracted from the leaves, petals, stems, seeds, or roots of plants (Butnariu 
and Sarac 2018). The term “essential oil” is thought to have come from the 
Swiss alchemist Paracelsus von Hohenheim in the 16th century (Nazzaro et al. 
2017), who used the term “Qunita essentia” to describe plant products 
produced via distillation (Guenther 2013). However, the use of oils extracted 
from plants has been documented much earlier than this (Baser and 
Buchbauer 2015). As early as 4500 B.C., ancient Egyptians recognised the 
therapeutic potential of oils extracted from plants (Boire 2013), and regarded 
them so highly that King Tutankhamen was buried with approximately 350 
litres of aromatic oils (Narayanasamy et al. 2019). China’s use of herbal 
medicine dates back to 3000 B.C., during the reign of Shen Nong Shi, whose 
work with medicinal plants is thought to be one of the earliest medical 
compendiums in China (Boire 2013). Commercial production and use of EOs 
is widespread globally, with over 100 countries producing EOs for decades 
(Govindasamy et al. 2013). However, of the ~3000 EOs known, only about 
300 are commercially used (Ghabraie et al. 2016). The oils most popular in 
the industrial sector include: orange, mint, eucalyptus, citronella, peppermint, 
and lemon, whilst oils most commonly intended for domestic use include: 
lavender, chamomile, peppermint, tea tree oil, eucalyptus, geranium, jasmine, 
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rose, lemon, orange, rosemary, frankincense, and sandalwood (Barbieri and 
Borsotto 2018). 
 
1.2.1.1 Extraction and composition  
Three methods are known to be used to extract essential oils from plants 
including expression, hydro-distillation and dry distillation (Baser and 
Buchbauer 2015). The most common of these extraction methods, hydro-
distillation, or steam distillation as it is otherwise known, is used throughout 
commercial production of EOs on industrial scales (Barreto and Coelho 2015). 
Extraction is usually expensive because of the relatively minimal return of final 
product from the raw material (Butnariu and Sarac 2018). For example, 
Semeniuc et al. (2017) found that parsley, basil and thyme yielded 0.16%, 
0.4% and 2.2% oil per gram of raw material, respectively. Soni et al. (2016) 
found that nutmeg yielded an average of 5.93 mL per 100g dry weight, López 
et al. (2018) obtained a 1.8% yield from lemongrass, and Zheljazkov et al. 
(2013) extracted a maximum yield of 6.8% oil from lavender. Many factors 
have an influence on yield of oil from plants including: the species of plant; the 
part of the plant the oil is extracted from; the drying conditions; the location of 
plant growth; the level of milling carried out on dry matter; and distillation times 
(Wang et al. 2009, Zheljazkov et al. 2013, Asbahani et al. 2015, Baser and 
Buchbauer 2015, Bowes and Zheljazkov 2019). Chemical composition of the 
oil is also dependent on many of these same factors (Eslahi et al. 2017), as 
well as seasonal variations (Zouari-Bouassida et al. 2018), maturity of the 
plant, and genetics, although the factors effecting composition and yield are 
often interconnected and influence each other (Dhifi et al. 2016). An essential 
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oil is a complex mixture of highly volatile substances (Butnariu and Sarac 
2018). The complexity can often reach over 300 different compounds, which 
belong to several different chemical classes including: alcohols, ethers, 
aldehydes, ketones, esters, amines, amides, phenols, heterocycles, and 
terpenes (Dhifi et al. 2016). Terpenes are the most represented family of 
compound within EOs and can be divided into monoterpenes, sequiterpenes 
and diterpenes, and also categorised as cyclic or acyclic (Buckle 2015). 
Because of the highly complex composition of EOs it is very difficult to replicate 
them synthetically in the lab (Butnariu and Sarac 2018).  
 
1.2.1.2 Known uses 
In nature, EOs have many roles in plant life. They are thought to protect the 
plant from disease, deter insects which may act as carriers of infection, repel 
predators or even entice pollinators (Nazzaro et al. 2017). Many people 
associate essential oils with aromatherapy, an alternative or complementary 
treatment that uses EOs (Lee et al. 2012). Populations from Egypt, China and 
India have been using EOs in aromatherapy for over 6000 years (Ali et al. 
2015) and it has been described in cancer care (Reis and Jones 2017), 
reduction of anxiety (Muzzarelli et al. 2006) and sleep improvement (Lin et al. 
2019). EOs, alone or in combination, have been used extensively for the 
treatment of wounds, inflammation, cystitis, rheumatic joints, skin sores, 
bleeding, fungal infections, burns, pharyngitis, syphilis, and leprosy 
(Narayanasamy et al. 2019). Commercially, EOs are usually destined for food 
and drink companies, perfume and fragrance companies, cosmetics, personal 
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care products and pharmaceuticals (Govindasamy et al. 2013). However, EOs 
have recently gained a lot of attention due to their antimicrobial properties. 
 
1.2.1.3 Essential oils as antimicrobials 
EOs have been used medicinally for many years and are widely reported as 
possessing antibacterial, antifungal and anti-plasmodial properties 
(Utchariyakiat et al. 2016). EOs have been described as one of the most 
promising natural products to combat fungal infections (Nazzaro et al. 2017). 
Work by Zabka et al. (2014) found that the antifungal activity of some 
essentials were similar to that of synthetic fungicides, and after an extensive 
review of the antifungal properties of essential oils reported in the literature, 
Whiley et al. (2018) found that clove oil was most researched and was a potent 
antifungal agent, as well as thyme, tea tree, oregano and citrus oils.  
The antiviral efficacy of EOs has also been evaluated. Brochot et al. (2017) 
found that blends of EOs were active against influenza virus and herpes 
simplex virus 1 (HSV-1), whilst Astani et al. (2011) revealed that EO from star 
anise was highly effective against HSV-1.  
EOs are extensively reported for their activity against both Gram-negative and 
Gram-positive bacteria in both motile and sessile states (Millezi et al. 2016). 
Janssen et al. (1986) screened 53 EOs for antibacterial activity against 
pathogens such as E. coli, P. aeruginosa, C. albicans, B. subtilis and S. 
aureus, and found that all of the oils showed activity against at least 1 of the 
organisms tested. In other studies, thyme, oregano, tea tree, cinnamon, lemon 
grass, bay laurel, lemon myrtle, clove, and rosewood EOs showed 
antimicrobial effects against E. coli at concentrations of <1%, with some oils 
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effective at concentrations as low as 0.02% (Nazzaro et al. 2019). Fine et al. 
(2007) found that in vivo tests evaluating the use of an EO-containing mouth 
rinse revealed significant reduction of oral pathogenic bacteria such as 
Porphyromonas gingivalis, Fusobacterium nucleatum and Veillonella sp., after 
2 weeks of use. EOs have also been shown to have synergistic effects when 
used in combination with antibiotics and even prevent transmission of 
resistance (Mulani et al. 2019). EOs have also been well documented for their 
antibiofilm activities (Budzyńska et al. 2011, Saviuc et al. 2015, Artini et al. 
2018, Kuhn et al. 2019, Mittal et al. 2019). 
EOs have even been studied in vitro for their potential use in treating cancer, 
for example, Oliveira et al. (2015) found that marigold EO showed no 
cytotoxicity in tumour cell lines. Because of the known volatility of EOs, their 
vapour phase has also been investigated for antimicrobial properties. In 1960, 
Maruzzella and Sicurella (1960) studied 133 EO vapours for antibacterial 
activity and found that thyme, cassia, cinnamon, origanum, and cherry laurel 
EO vapour inhibited a broad spectrum of bacteria. More recently, EO vapours 
have been used to inhibit moulds in food products (Ji et al. 2019); eradicate 
pneumonia causing bacteria (Houdkova et al. 2018); and combat biofilm 
forming bacteria (Benzaid et al. 2019). 
 
1.2.1.4 Modes of action of essential oil 
The antimicrobial activity of EOs against organisms can be related directly, but 
not exclusively, to their composition, configuration, volume and interactions 
with the pathogen. EOs can affect one or multiple targets within 
microorganisms (Dhifi et al. 2016) and their mode of action as whole oil is most 
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likely to be attributed to their composition. Essential oils are usually described 
as having 2 or 3 major constituents, often representing up to 85% of the entire 
composition, and usually responsible for the biological activity the oil exerts 
(Chouhan et al. 2017). However, it has been shown that the minor components 
often have a role to play as well (Feyaerts et al. 2018). The chemical class of 
the antimicrobial constituent typically eludes to the mechanism of action of the 
oil against bacteria (Swamy et al. 2016). Oils with a high proportion of 
aldehydes and phenols usually have a strong antimicrobial activity, whilst 
those with ketones, esters or terpene hydrocarbons have a weaker activity, or 
lack any antimicrobial efficacy at all (Bassolé and Juliani 2012). One of the 
most important characteristics of oil EOs is their hydrophobicity, which results 
in increased cell permeability and leads to cell leakage (Dhifi et al. 2016). The 
majority of EOs act on the cell wall or membrane of bacteria and can cause 
the release of lipopolysaccharides from the membrane (Faleiro 2011). 
Intracellular and external ATP balances are likely to be affected as well as 
protein synthesis, pH fluctuation, intracytoplasmic changes such as 
coagulation of cytoplasmic material, DNA disruption and inhibition of quorum 
sensing (Faleiro 2011, Lopez-Romero et al. 2015). Processes influencing 
energy conversion, nutritional balances, structural macromolecule synthesis 
and growth regulation have all been reportedly effected by EOs (Swamy et al. 
2016).  
Phenolic compounds, for example carvacrol, eugenol and thymol, have 
reportedly affected the cytoplasmic membrane, proton forces, electron flow, 
active transportation and cell content coagulation (Dhifi et al. 2016). It is also 
reported that components contributing to the composition of EOs may have a 
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synergistic, additive or antagonistic effect on one another (Pei et al. 2009), 
therefore it is essential to have a clear understanding of the composition of 
any particular EO, to have a clear understanding of mode of action.    
 
1.2.1.5 Safety 
The majority of EOs are classified by the Food and Drug Administration as 
generally recognised as safe (GRAS), and several have been approved for 
use in food applications and for consumption (Ali et al. 2015). The most 
common adverse reaction encountered from EOs is typically a result of 
individual hypersensitivity, and risks are usually controllable (Rather et al. 
2016). Common complaints caused by EO interactions are related to eye, 
mucous membrane and skin irritation or sensitization (Ali et al. 2015). 
However, more serious cases of toxicity have been reported where vomiting, 
epigastric pain, diarrhoea, convulsions, renal failure, and central nervous 
system depression have been observed (Eisenhut 2007). The toxicity of an oil 
can be increased by improper storage, which could lead to photoisomerisation, 
photocyclisation, oxidation, peroxidation and decomposition of alcohols, 
ketone hydrolysis, and overall degradation, potentially reducing the safety of 
an EO (Sarkic and Stappen 2018). Whilst toxicity testing on EOs is often 
limited to specific named EOs, several studies have investigated the toxicity 
of oils in vivo in rodent and small mammal models. For example, Mekonnen et 
al. (2019) found that lavender EO was not toxic when evaluated orally and 
dermally in mice and rabbits.  In vitro studies have also been used to access 
toxicity of oils in human cell lines. Puškárová et al. (2017) looked at the toxicity 
of several essential oils when introduced to human embryo lung cells and 
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found that none of the oils induced any genotoxic effects. There have been 
reports of accidental or intentional ingestion of EOs in humans, although in 
cases where citronella EO was ingested no toxicity was shown (Vigan 2010), 
and where near fatal incidents have occurred, consumption was thought to be 
at extremely high doses (Nath et al. 2012). With safety in mind, it is sensible 
to suggest that toxicity of most oils can be circumvented by avoiding ingestion, 
diluting oil for topical applications and ensuring proper storage (Hammer et al. 
2006). 
 
1.3 Summary and aims  
The increasing development of resistant bacteria is putting an enormous strain 
on the current repertoire of antimicrobials. This global crisis of AMR is the 
result of years of antibiotic abuse and misuse, among other drivers of 
resistance. AMR is a financial burden to the whole world and is already having 
a catastrophic effect on the population. Concerted efforts must be made to 
develop new policies of use, continue research efforts, and develop novel 
interventions to mitigate this threat. Combatting those bacteria most highly 
implicated in this crisis, and specifically focussing on the mechanisms of 
resistance that they possess, is fundamental in the development of successful 
antimicrobials. EOs are a naturally occurring product of plants and have 
historically been used as antimicrobials, but many EOs remain neglected in 
research.  
The aims of this thesis are to explore EOs as alternative antimicrobials, to 
investigate their anti-biofilm activity and to evaluate their potential to contribute 
to the control of AMR. These aims hope to support or refute the hypotheses 
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that EOs will be effective antimicrobials with the ability to combat biofilms, EOs 
could be successfully incorporated into future development of new 
antimicrobials that can aid in the reduction of AMR, and that investigation into 
EOs as novel antimicrobials is warranted.  
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2 MATERIALS AND METHODS 
2.1 Chemicals and media 
All chemicals and media used in this study were purchased from Sigma Aldrich 
(Dorset, UK), Oxoid (Hampshire, UK) or Fisher Scientific (Leicestershire, UK), 
unless otherwise specified. All media were made using deionised water and 
sterilised by autoclave, unless otherwise specified.  
 
2.2 Maintenance and growth of bacteria 
Bacteria tested throughout this study were obtained from the microbiology 
culture collection at the University of the West of England, Bristol, UK. The 
strains used were: Escherichia coli (Strain B; ATCC 23848), Escherichia coli 
(NCTC 9001), Escherichia coli (ATCC 10536), Staphylococcus aureus (ATCC 
6538), Staphylococcus aureus (NCTC 12981), Pseudomonas aeruginosa 
(PAO1), Pseudomonas aeruginosa (NCTC 8505), Pseudomonas aeruginosa 
(ATCC 15442), Hospital Acquired Methicillin-Resistant Staphylococcus 
aureus (MRSA) isolate, Methicillin-Susceptible Staphylococcus aureus 
(MSSA; NCTC 13297), Acinetobacter baumannii (NCTC 12156), 
Acinetobacter baumannii (ATCC 17978) and Enterococcus hirae (ATCC 
10541). All bacteria were stored on beads (Microbank, Pro Lab Diagnostics, 
Canada) at -80°C and revived on nutrient agar (NA; Oxoid, Hampshire, UK) 
slopes at 37°C for 24 h. These slopes were kept at 4°C as working cultures for 
a maximum of 6 weeks. Overnight broth cultures were prepared using one to 
three colonies of bacteria from these slopes, which were added to 10 mL of 
tryptone soy broth (TSB; Oxoid, Hampshire, UK) and incubated at 37°C for 24 
h. When required, cultures were standardised by diluting with TSB and 
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measuring optical density at 600 nm to obtain a reading of 0.08-0.1 (McFarland 
0.5), giving a standardised inoculum of ~1-2 x 108 CFU mL-1. 
 
2.3 Essential oils 
Fifteen essential oils were used, and included EOs from: bergamot (Citrus 
bergamia; peel), cinnamon (Cinnamomum zeylanicum; bark and leaf), clove 
(Eugenia caryophyllus; bud), grapefruit (Citrus paradise; peel), lavender 
(Lavandula angustifolia; flower), lemon (Citrus limonum; peel), lemongrass 
(Cymbopogon citratus, dried grass), lime (Citrus aurantifolia, fruit), manuka 
(Leptospermum scoparium; leaves), sweet orange (Citrus sinensis; peel), rose 
geranium (Pelargonium graveolens; whole plant), rosemary (Rosmarinus 
officinalis; leaves), North Indian rosewood (Dalbergia sissoo; wood), tea tree 
(Melaleuca alternifolia; leaves) and thyme (Thymus vulgaris; whole plant). All 
of these oils were donated by Amphora Aromatics Ltd, Bristol, UK for research 
purposes, with the exception of cinnamon leaf oil which was purchased 
separately and manufactured by Natural by Nature Ltd, UK. Oils were 
considered to be at 100% concentration in their neat form and subsequent 
dilutions stated as a percentage (v/v) reflects this.  
 
2.3.1 Oil analysis 
Gas Chromatography Mass Spectrometry (GC-MS) analysis of cinnamon bark 
EO was performed using methods adapted from Adukwu et al. (2012). 
Cinnamon leaf EO was also analysed as a comparator to the bark EO to 
identify the differences in the components as these EOs are obtained from 
different parts of the same plant. GC-MS analysis used an Agilent 6890N 
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Network Gas Chromatograph system and 5973 Network Mass Selective 
Detector (Agilent Technologies, USA). Samples were dissolved in acetone 
with a 1 µL injection volume. Inlet temperature was 300°C with a split ratio of 
10:1. Temperature of the transfer line was 300°C and solvent delay was 3 min. 
The carrier gas was helium with a column flow rate of 1 mL min-1 and operating 
at constant flow. The oven temperature started at 50°C and was held for 2 
min, then increased until 280°C was reached at a rate of 10°C min-1, with a 
total run time of 25 min. Compound separation was achieved with a HP-5MS 
column (30 m × 0.25 mm × 0.25 µm). An electron impact ion source at 230°C, 
and a quadrupole mass analyser at 150°C was used. Electron ionization mass 
spectrometric data were collected between 30 to 550 m/z. Oil components 
were identified by comparison of mass spectral patterns with those from the 
spectra from the National Institute of Standards and Technology (NIST) library 
(MS Search 2.0) provided by the software of the GC-MS system.  
 
2.3.2 Preparation of essential oils (EOs) 
Where EO was required at different concentrations, unless otherwise 
indicated, a stock solution of EO was prepared in TSB containing dimethyl 
sulfoxide (DMSO; Sigma Aldrich, Dorset, UK) which is a solvent used as a 
dispersal agent (Kačániová et al. 2017). Further two-fold dilutions of this stock, 
in TSB, produced a range of EO concentrations from 0.015% to 8% (v/v), with 
DMSO concentrations of 0.0098% to 5% (v/v), respectively.  This produced an 
EO to DMSO ratio of 1:0.625, which was maintained throughout experiments 
in this thesis.  
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2.4 Biofilm growth in vitro 
2.4.1 Microtitre plate method (crystal violet biofilm assay) 
Methods for assessing in vitro biofilm growth were adapted from Stepanović 
et al. (2000). An overnight culture was standardised as described in section 
2.2, with the exception of being diluted in TSB supplemented with 1% (v/v) 
glucose. Two hundred microliters of this suspension were added to each well 
of the microtitre plate. Three wells each were used per bacterial strain, 
ensuring adequate spacing between each to avoid risk of contamination. 
Negative control wells contained TSB with 1% glucose only. Plates were 
incubated at 37°C for 24 hours. The wells were then carefully aspirated and 
washed three times using 250µl of sterile PBS. Bacteria were fixed using 200µl 
of methanol for 15 minutes, wells were emptied and then air dried. After air 
drying, wells were stained with 250µl of 0.1% crystal violet for 5 minutes. 
Excess stain was removed by rinsing gently with tap water. After leaving to air 
dry, the bound stain was solubilised with 250µl of 33% (v/v) acetic acid. The 
optical density (OD) of wells in the plate was then measured using a TECAN 
Infinite® 200 PRO plate reader at OD595nm. Biofilm growth was categorised by 
strength of adherence which was defined as: non-adherent, weak, moderate 
and strong. This classification depended on the OD values of wells and its 
comparison to the OD cut-off (ODc) value. ODc was defined as three standard 
deviations above the mean OD of the negative control. Experiments were 
carried out independently in triplicate and categorisation of biofilms was based 
on the following formulae:  
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𝑂𝐷 ≤ 𝑂𝐷𝑐 =  𝑛𝑜𝑛-𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡  
𝑂𝐷𝑐 < 𝑂𝐷 ≤ 2 × 𝑂𝐷𝑐 = 𝑤𝑒𝑎𝑘𝑙𝑦 𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡 
2 × 𝑂𝐷𝑐 < 𝑂𝐷 ≤ 4 × 𝑂𝐷𝑐 =  𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒𝑙𝑦 𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡 
𝑂𝐷 > 4 × 𝑂𝐷𝑐 = 𝑠𝑡𝑟𝑜𝑛𝑔𝑙𝑦 𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡  
 
2.4.2 CDC biofilm reactor  
A Centre for Disease Control (CDC) Biofilm Reactor (CBR; model CBR 90-2; 
BioSurface Technologies, USA) was used to produce biofilms under high 
shear and continuous flow (Figure 2.1). Full specifications for this equipment 
and its use can be found in the manufacturer’s manual. Briefly, it consists of a 
1 L Pyrex beaker with an outlet port at 400 mL, resulting in an approximate 
working volume of 350 mL. The ultra-high molecular weight (UHMW) 
polyethylene ported lid holds 8 polypropylene rods, which each accommodate 
3 coupons (1.27 cm width, 0.3 cm thickness). Medium is circulated through the 
vessel and the shear is generated by a magnetic baffle and digital stir plate. 
Coupons used were polycarbonate or stainless steel, and they were cleaned 
by sonicating for 5 min in 1:1000 Decon90 (Fisher Scientific, Leicestershire, 
UK), rinsing in deionised water, followed by a 5 min sonication in deionised 
water. Polycarbonate coupons underwent a further 2 h soak in 2 M 
hydrochloric acid. Coupons were left to air dry in Petri dishes lined with filter 
paper. The assembled CBR, including cleaned coupons, was filled with 500 
mL of 300 mg L-1 TSB and autoclaved at 121°C for 15 min. Once cooled, the 
reactor was inoculated with 1 mL of standardised P. aeruginosa culture and 
placed on a digital stir plate operating at 130 rpm at room temperature. The 
CBR was operated in batch phase for 24 h, followed by continuous flow phase 
36 
using 100 mg L-1 TSB at a flow rate of 11.6 mL min-1 for a further 24 h. This 
produced standardised 48 h mature biofilms. 
 
 
 
 
 
Figure 2.1 – Centre for Disease Control (CDC) biofilm reactor. 
 A diagram depicting the assembled vessel of the CDC biofilm reactor used to 
grow biofilms under continuous flow and medium-high shear force. Image 
created by author. 
37 
2.5 Imaging 
2.5.1 Scanning electron microscopy (SEM) 
Samples for SEM were prepared using the method reported by Murtey and 
Ramasamy (2016) and adjusted as indicated below. Briefly, small squares of 
poly-l-lysine coated microscope slides (Sigma Aldrich, Dorset, UK) were 
placed in wells of a 12-well plate. Wells were inoculated with 1 mL of bacterial 
samples in broth culture and left to adhere for 1 h. The squares of microscope 
slide were removed and placed in a new 12-well plate. The attached cells were 
then fixed by immersion in 4% (v/v) glutaraldehyde (Sigma Aldrich, Dorset, 
UK) in 0.1 M phosphate buffer (10.22 g L-1 Na2HPO4, 3.36 g L-1 NaH2PO4) for 
30 min, washed with the same buffer three times and then dehydrated through 
a series of ethanol concentrations for 10 min each, followed by 
hexamethyldisilizane (HMDS; Sigma Aldrich, Dorset, UK) for 10 min two times. 
The squares were mounted on aluminium stubs (Agar Scientific Ltd, Essex, 
UK) and coated with gold in a sputter coater and viewed using a scanning 
electron microscope (FEI Quanta 650 FEG, Sigma Aldrich, UK). 
 
2.6 Data analysis 
The following data analysis was carried out, unless otherwise specified. Data 
were analysed using Microsoft Excel 2016 (Microsoft Corporation, Redmond, 
USA) and GraphPad Prism version 8.00 for Windows (GraphPad Software, La 
Jolla California, USA). Minimum level of significance was set to P<0.05, and 
where asterisks were used to indicate significance: * = P<0.05; ** = P<0.01; 
*** = P<0.001; **** = P<0.0001.  
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3 THE ANTIMICROBIAL ACTIVITY OF ESSENTIAL OILS  
 
3.1 Introduction 
Many essential oils (EOs) are well described to have antimicrobial activity 
(Millezi et al. 2016). Despite the widespread use of EOs for multiple purposes, 
only a small proportion of the known EOs are used commercially (Ghabraie et 
al. 2016). Whilst it is thought that the majority of EOs act on the cell wall and 
membrane of bacteria (Faleiro 2011), studies assessing mode of action of 
individual oils are still required. Furthermore, very few studies exploring the 
antimicrobial activities of EOs investigate their potential for rapid killing, i.e. 
under 10 min contact time. Friedman et al. (2004) investigated the activities of 
EOs and their components against E. coli O157:H7 with incubation times of 
≥5 min, and Tangjitjaroenkun et al. (2012) studied the antimicrobial effects of 
EO from Zanthoxylum limonella with incubation times of ≥3 min. Mayaud et al. 
(2008) assessed the inhibitory action of various EOs against bacteria with 
contact times of ≥5 min. However, to my knowledge, to date no study has 
evaluated the antimicrobial efficacy of EOs against P. aeruginosa with less 
than 5 min contact time. As part of the search for novel antimicrobials, efficacy 
of new antimicrobial compounds must be quantitatively assessed using 
antimicrobial screening assays. These often include broth dilution methods to 
determine the minimum inhibitory concentration (MIC), a value representing 
the lowest concentration of antimicrobial required to inhibit microorganism 
growth. Dimethyl sulfoxide (DMSO) is a clear odourless liquid which acts as 
an aprotic solvent (Brayton 1986). It has a strong affinity to and is soluble in 
water, but can also solubilise in ethanol, acetone, diethyl ether, benzene and 
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chloroform (Pope and Oliver 1966). It is a useful solvent for compounds such 
as therapeutic and toxic agents, which are not soluble in water, and is often 
used in place of methanol or ethanol when these two solvents are incapable 
of dissolving a compound of interest (Wadhwani et al. 2012). It is important to 
consider any possible effects that these supplements have on the outcome of 
such experiments, and whether they would interfere with the results. 
Therefore, this chapter first aims to investigate the potential effects of DMSO 
on the chosen panel of bacteria, whether it enhances or suppresses growth 
and if it influences the outcome of antimicrobial testing. As previously 
described, there is a large breadth of essential oils available to investigate, 
therefore this chapter further aims to assess the effects of a selection of EOs 
against a panel of bacteria, with the aim to streamline investigations to focus 
on one selected EO, exhibiting the greatest antimicrobial effects, and 
investigate its rapid bactericidal potential and mode of action. 
 
 
3.1.1 Chapter progression 
The following flow diagram depicts a summary of the progression of this 
chapter. 
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3.2 Methods 
3.2.1 Test organisms and standardisation of overnight cultures 
The bacteria used included Escherichia coli (ATCC 23848), Escherichia coli 
(NCTC 9001), Staphylococcus aureus (ATCC 6538), Staphylococcus aureus 
(NCTC 12981), Pseudomonas aeruginosa (PAO1), Pseudomonas aeruginosa 
(NCTC 8505), Hospital Acquired Methicillin-Resistant Staphylococcus aureus 
(MRSA) isolate, Methicillin-Susceptible Staphylococcus aureus (MSSA; NCTC 
13297), Acinetobacter baumannii (NCTC 12156), Acinetobacter baumannii 
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(ATCC 17978). Their storage and standardisation were carried out as 
described in section 2.2. 
 
3.2.2 Effect of dimethyl sulfoxide (DMSO) on bacterial growth 
Methods to assess the effect of DMSO on bacterial growth were adapted from 
those previously described by Wadhwani et al. (2012). Standardised overnight 
cultures were further diluted in TSB (1:150) and 100 µL of this (approximately 
5x105 CFU mL-1) was added to the wells of a 96-well microtitre plate. 
Concentrations of 2.5% and 5% DMSO were prepared in TSB and 100 µL of 
each concentration was added to the inoculated wells to give final 
concentrations of 1.25% and 2.5%. Microtitre plates were incubated at 37°C 
for 24 h. Contents of wells were diluted and 100 µL spread onto NA agar 
plates, which were incubated for 24 h at 37°C and then enumerated. TSB and 
bacterial culture in equal parts was used as a negative control. DMSO and 
TSB alone were also included to ensure no contamination was present. Each 
organism was grown in triplicate and three independent experiments were 
carried out. Final values are expressed as mean CFU mL-1. 
 
3.2.3 Headspace analysis of E. coli in DMSO by selected-ion flow-tube mass 
spectrometer (SIFT-MS) 
Methods to assess headspace of broth culture were adapted from methods 
outlined by Slade et al. (2017). Briefly, 9 mL of 1.25% DMSO in TSB was 
added to sterile 250 mL glass bottles with a screw cap containing a silicone 
septum. A standardised overnight culture of E. coli (ATCC 23848) was diluted 
1:150 and 1 mL of this suspension was used to inoculate the glass bottles. A 
 45 
 
glass bottle containing only TSB with culture was used as a negative control.  
Bottles were incubated for 4 h at 37°C. Headspace analysis of the culture was 
analysed using a SIFT-MS (Instrument Science Limited, UK) in ‘Full Mass 
Scan’ mode and an H3O+ precursor ion was used. A sterile needle attached 
to the SIFT-MS direct sampling inlet was used to pierce the silicon septum of 
the sample bottle and the sample was vented using another sterile needle 
(Fisher Scientific, Leicestershire, UK) attached to a 0.2 µm syringe filter 
(Sartorious Stedim Biotech, Germany) to allow for free-flowing headspace 
gases. Three analyses were carried out using repeat scans of 60 s, over a 
spectrum range of 10–200 m/z, and three independent experiments were 
carried out. 
 
3.2.4 Quantification of metabolites produced by E. coli in presence of DMSO 
using SIFT-MS 
Headspace analysis identified a dominant peak relating to the presence of 
dimethyl sulfide (DMS); thus, the following method was used to quantify this 
compound. Briefly, the headspace of the chamber was analysed using a SIFT-
MS in ‘Selected Ion’ mode to quantify headspace concentration of DMS. H3O+, 
NO+ and O2+ were used as precursor ions. A sterile needle attached to the 
SIFT-MS direct sampling inlet was used to pierce the silicon septum of the 
vapour chamber and the sample was vented using another sterile needle 
attached to a 0.2 µm syringe filter to allow for free-flowing headspace gases. 
Three analyses were carried out using repeat scans of 90 s and three 
independent experiments were carried out. Final values were calculated as 
mean parts per billion (ppb).  
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3.2.4.1 Influence of DMSO on antimicrobial testing 
The broth dilution method of antimicrobial testing was used in future chapters 
of this thesis to determine minimum inhibitory concentration (MIC) and used 
DMSO as a solvent. An alternative method was employed to evaluate whether 
the presence of DMSO influenced the results. The agar dilution method, which 
was not chosen for studies within this thesis, but widely used in other studies, 
does not employ DMSO as a solvent. Thus, this method was used to 
determine the MIC of cinnamon bark, clove and tea tree essential oil against 
E. coli B (ATCC 23848) and the results compared to those from MIC testing 
described in chapter 4. Methods used here were adapted from Clinical and 
Laboratory Standard Institute (CLSI; 2012) and Griffin et al. (2000). Briefly, 
MHA agar was prepared and supplemented with 0.5% Tween 20 (v/v). 
Essential oil was added to 15 mL aliquots of this molten agar, to achieve 
doubling concentrations ranging from 0.03% to 2% (v/v). Molten agar was 
mixed thoroughly, whilst avoiding production of bubbles, and poured into petri 
dishes and allowed to set at room temperature. A standardised overnight 
culture of E. coli B (ATCC 23848) was prepared as described in section 2.2 
and further diluted 1:150 in TSB. Once the prepared agar plates were dry, 
plates were inoculated with 10 µL spots of diluted culture. One agar plate 
inoculated with the test organism in the absence of essential oil was used as 
a negative control with each experiment. Each plate was inoculated with three 
spots and three independent replicates were carried out. 
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3.2.5 Essential oils 
The EOs used in this chapter are described in section 2.3.  
 
3.2.6 Disc diffusion assay 
Screening of EOs for anti-bacterial activity was performed using a paper disc 
diffusion approach adapted from the Clinical and Laboratory Standards 
Institute (CLSI) Antimicrobial Susceptibility Testing (AST) Standards (Clinical 
and Laboratory Standards Institute 2015). MHA plates were inoculated with 
100 μL of standardised culture for each test bacterium, spread evenly over the 
entire surface of the agar using a sterile cotton swab by swabbing in three 
directions (Howe and Andrews 2012). The inoculum applied to each plate was 
~1-2 x 107 CFU mL-1. A volume of 10 μL of EO was used to saturate a set of 
six mm diameter filter paper discs (Whatman, Sigma Aldrich, UK), one of which 
was then placed onto the centre of each inoculated plate. Sterile discs (6mm) 
without EO were used as a negative control and discs containing 30 μg 
gentamicin (Oxoid, Hampshire, UK) were used as a positive reference. Plates 
were incubated at 37°C for 24 h and antibacterial activity was assessed by 
measuring the diameter of the zones of inhibition in mm using Vernier callipers. 
Three independent experiments were performed in triplicate. 
 
3.2.7 Determination of minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC)  
The MIC of EOs was determined by the broth microdilution method as outlined 
by the CLSI (2012) and adapted from previously described methods (Cao et 
al. 2009). EO dilutions were prepared as described in section 2.3.2. One 
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hundred microliters of each EO concentration were added to wells of a 96-well 
microtitre plate. A standardised overnight culture (as described in section 2.2) 
was diluted 1:150 with TSB, and 100 µL of this was added to each well of the 
microtitre plate. Final concentrations of EO ranged from 0.007% to 4% (v/v) 
with DMSO concentrations of 0.0049% to 2.5% (v/v) respectively. Final cell 
density of the inoculum was approximately 5 x 105 CFU mL-1. Microplate wells 
of EO dilutions without bacteria, and TSB and DMSO alone, were used as 
negative controls, and plates were incubated at 37°C for 24 h. MIC values 
were determined by the well with the lowest concentration of EO where no 
visible microbial growth was observed. Each concentration of EO had three 
replicates and experiments were independently repeated four times. 
MBC was determined by spot inoculation similar to methods outlined by 
Adukwu et al. (2012). Briefly, 10 µL was pipetted from the microtitre wells 
showing no growth onto MHA, and incubated for 24 h at 37°C. Each 
concentration of EO had three replicates and experiments were independently 
repeated four times. MBC values were determined as the lowest concentration 
of EO where no growth was observed. 
 
3.2.8 Gas chromatography mass spectrometry (GC-MS) analysis 
Following determination of MICs and MBCs, cinnamon bark EO demonstrated 
broad-spectrum activity against all tested organisms, including P. aeruginosa 
at <4% (v/v). Thus, this oil was selected for testing rapid bactericidal effects 
against P. aeruginosa. 
GC-MS analysis of cinnamon bark EO was performed as described in 2.3.1. 
Cinnamon leaf EO was also analysed as a comparator to the bark EO, to 
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identify the differences in the components, as these EOs are obtained from 
different parts of the same plant species. 
 
3.2.9 Time-kill assay 
Time kill kinetics were determined for cinnamon bark EO against P. 
aeruginosa PAO1 using methods adapted from Carson et al. (2002). Six 50 
mL conical flasks containing 15 mL of TSB were inoculated with 50 µL of 
standardised P. aeruginosa PAO1 overnight culture to achieve approximately 
5 x 105 CFU mL-1. A 100 µL aliquot was removed from each flask and added 
to 9.9 mL of TSB, diluted serially and plated onto MHA to confirm starting 
inoculum density, representing the zero min time point (T0). Table 3.1 shows 
the volumes of EO and DMSO added to the flasks to achieve a series of 
concentrations for the time-kill assay. The concentration of cinnamon bark EO 
ranged from 0.125% (v/v; 1 x MIC) to 2% (v/v; 16 x MIC), with a negative 
control flask containing DMSO alone. After the addition of EO and DMSO, the 
flasks were vortexed and incubated without shaking at room temperature. At 
each time point the flasks were vortexed again and aliquots were removed at 
2, 4, 6, 10 and 30 min and at 1, 2, 4, 6 and 24 h, diluted serially and plated 
onto MHA. All plates were incubated at 37°C for 24 h before enumeration of 
the colonies. The effect of an antimicrobial compound is considered 
bactericidal if a ⩾99.9% decrease in the initial inoculum (i.e. a three-log 
reduction) is observed, as described by the CLSI (1999).   
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3.2.10 Metabolic activity assay 
A triphenyltetrazolium chloride (TTC) metabolic activity assay was performed 
to investigate the effect of EO on metabolic activity during the time-kill assay, 
as described by Ahmed (2013). One hundred microlitre aliquots of the treated 
organisms from each time point were transferred to wells of a 96-well plate. A 
5 µL volume of sterile 1% aqueous solution of TTC (Sigma Aldrich, Dorset, 
UK) was added to each well and plates were wrapped in aluminium foil and 
incubated at 37 °C with orbital shaking at 120 rpm for 24 h. TSB containing no 
bacteria was used as a negative control. The presence of viable bacterial cells 
was indicated by the reduction of the yellow TTC to a red colour. Optical 
density of the wells was measured using a TECAN Infinite® 200 PRO plate 
Table 3.1 – Preperation of Essential Oil Dilutions. 
Volumes of EO and DMSO prepared before adding to flasks containing 15 mL 
TSB inoculated with P. aeruginosa to achieve range of final cinnamon bark EO 
concentrations 
Concentration of 
EO required 
(v/v) 
Volume of EO 
added (µL) 
Volume of 
DMSO added 
(µL) 
0% 0 187.5 
0.125% 18.8 11.7 
0.25% 37.5 23.4 
0.5% 75 46.9 
1% 150 93.8 
2% 300 187.5 
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reader at 595 nm. Data were normalised to T0 and expressed as a percentage 
relevant to this time point. All assays were performed in triplicate on three 
separate occasions. 
 
3.2.11 Scanning electron microscopy (SEM) 
SEM was used to assess morphological effects on P. aeruginosa PAO1 after 
treatment with cinnamon bark EO at 2% (v/v) for 10 min. Both untreated and 
treated samples were prepared for SEM as described in section 2.5.1. 
 
3.2.12 Release of nucleic acids and proteins  
The release of 260 nm absorbing nucleic acids and 280nm absorbing proteins 
from P. aeruginosa PAO1 after treatment with cinnamon bark EO was 
measured according to methods described by Miksusanti et al. (2008), with 
some adaptations. A 50 mL conical flask containing 15 mL of cinnamon bark 
EO at either 2% (v/v) or 1.25% (v/v) in TSB with 1.25% (v/v) or 0.08% (v/v) of 
DMSO, respectively, was inoculated with 50 µL of standardised overnight P. 
aeruginosa PAO1 culture. The flask was vortexed, incubated at room 
temperature for 2 h and then a 1 mL aliquot was removed and filtered with 
0.45 µm filter (Sartorious Stedim Biotech, Germany). The absorbance of this 
filtrate was measured at 260 nm and 280 nm. Negative controls were treated 
with DMSO (1.25% v/v) alone. The absorbance of filtrate from controls without 
culture added were deducted from the absorbance of the respective samples 
with EO added. Experiments were performed in triplicate on three separate 
occasions, and results are expressed as mean OD of nucleic acids (260 nm) 
and protein (280 nm) released.   
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3.2.13 Data analysis 
A one-way ANOVA with Tukey’s multiple comparisons test was used to 
compare means of growth of bacteria in absence or presence of DMSO at 
different concentrations. A two-tailed t-test was used to identify significant 
differences in DMS production when in presence or absence of DMSO. 
 
 
3.3 Results 
3.3.1 Effect of dimethyl sulfoxide (DMSO) on bacterial growth  
The effects of DMSO solvent on bacterial growth are presented in Figure 3.1. 
DMSO at either 1.25% or 2.5% (v/v) had little to no effect on the growth of any 
organism, with the exception of E. coli B (ATCC 23848). E. coli B (ATCC 
23848) in the presence of either concentration of DMSO showed a promotion 
of growth, double that of the control, and produced an unpleasant odour after 
overnight incubation.  
 
3.3.2 Headspace analysis of E. coli in DMSO by selected-ion flow-tube mass 
spectrometry (SIFT-MS) 
Due to the growth promotion and odour observed for E. coli B (ATCC 23848), 
further investigations were made to analyse the headspace of the culture in 
the presence of DMSO. A noticeable peak at 63 m/z, coupled with 
identification using the built-in compound library, indicated a production of 
DMS that was more than 100-fold greater in the culture with DMSO present. 
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3.3.3 Quantification of metabolites produced by E. coli in presence of DMSO 
using SIFT-MS 
Results from further quantification investigations are presented in Figure 3.2. 
When E. coli is in the presence of 1.25% (v/v) DMSO, DMS production is 
significantly greater than when E. coli is not exposed to DMSO (P<0.05). DMS 
produced in the presence of DMSO was determined to be 10434.8 ppb whilst 
DMS produced in the absence of DMSO was 2.3 ppb. 
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3.3.4 Influence of DMSO on antimicrobial testing 
A comparison of results from two methods of MIC testing are shown in Table 
3.2. Both methods produced the same MIC values for the oils tested. DMSO 
did not have a negative or beneficial effect when used as a solvent in 
antimicrobial testing. 
 
 
 
 
3.3.5 Disc diffusion assay 
The results from the antimicrobial susceptibility screening assay demonstrated 
that all the EOs used in this study were antimicrobial against most, if not all, 
the bacteria tested (Table 3.3). Three of the EOs, cinnamon bark, clove and 
thyme, produced zones of inhibition against all strains tested, including P. 
aeruginosa PAO1, demonstrating broad spectrum activity. Inhibition zones 
shown by thyme and cinnamon bark EO were significantly larger (P<0.05) than 
that of the gentamicin antibiotic reference in 70% and 60% of the strains used, 
respectively. Thyme produced zones of inhibition ranging from 17.1 - 48.2 mm, 
Table 3.2 – Effect of DMSO on Antimicrobial Activity. 
Comparison of MIC (% v/v) results for essential oils against E. coli B (ATCC 
23848) determined using broth microdilution method and agar dilution method 
(N=3). 
 Essential Oil 
Broth Microdilution MIC 
(% v/v) 
Agar Dilution MIC 
(% v/v) 
Cinnamon Bark 0.03 0.03 
Clove 0.125 0.125 
Tea tree 1.0 1.0 
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whilst cinnamon bark produced zones ranging from 16.7 – 36.2 mm. Rose 
geranium EO showed activity against all strains excluding P. aeruginosa 
NCTC 8505, producing zones ranging from 5.3 – 18.3 mm. Cinnamon leaf EO 
showed activity against all strains excluding P. aeruginosa PAO1, producing 
zones ranging from 8.7 – 18.2 mm. Lavender, lemongrass, lime, rosemary, 
rosewood and tea tree EOs showed effects against both Gram positive and 
Gram negative bacteria, excluding the Pseudomonas species. Of these oils, 
lemongrass produced the largest zones of inhibition, ranging from 10.1 - 36.9 
mm. The smallest zones of inhibition were produced by bergamot, grapefruit, 
lemon, manuka and sweet orange EOs. Blank disc negative controls did not 
affect the growth of any of the strains. In accordance with the breakpoint tables 
for inhibition zone interpretation published by the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST 2018), all bacteria in this study 
were sensitive to gentamicin with the exception of MRSA and A. baumannii 
NCTC 12156.  
 
3.3.6 Determination of minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC)  
Nine EOs were selected, based on their antimicrobial activity shown in the disc 
diffusion assay, to determine their MIC and MBC (Table 3.4). The data shows 
that rose geranium, rosewood and tea tree EOs produced MICs between 0.5 
and 4% or greater (v/v) against most strains and that MBC values for these 
are either equal or double the MIC value. Although Manuka EO demonstrated 
a MIC as low as 0.06% (v/v), the inhibitory effects were only against Gram-
positive S. aureus strains. Manuka EO did not demonstrate any bactericidal 
 59 
 
action at <4% (v/v). Thyme, lemongrass, cinnamon leaf and clove EOs 
presented MICs and MBCs of ≤1.0% (v/v) for all strains of bacteria excluding 
the P. aeruginosa strains. The only EO which demonstrated broad spectrum 
antimicrobial activity was cinnamon bark EO. All the bacteria tested including 
the Pseudomonas spp. were inhibited by cinnamon bark EO at ≤0.25% (v/v), 
which also demonstrated bactericidal activity at the same concentration. 
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3.3.7 Gas chromatography mass spectrometry (GC-MS) analysis 
Components of cinnamon bark and cinnamon leaf EO and their percentage 
composition are reported in Table 3.5. Cinnamon bark EO is composed of 
85.312% Σ-cinnamaldehyde, whereas cinnamon leaf EO is 84.481% eugenol. 
 
3.3.8 Time-kill assay 
A time-kill assay was performed to evaluate the bactericidal potential of 
cinnamon bark EO against P. aeruginosa PAO1 (Figure 3.3). At the MIC, 
0.125% (v/v), cinnamon bark EO was bactericidal (three-log reduction) against 
P. aeruginosa PAO1 after 6 h. At concentrations two-fold and four-fold of the 
MIC, 0.25% (v/v) and 0.5% (v/v), a 99.999% (five-log) kill, was achieved within 
30 and 6 min respectively. At the higher EO concentrations of 1% and 2% 
(v/v), 5-log reduction was achieved within 2 min.
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Table 3.5 – Analysis of Cinnamon Bark and Leaf Essential Oil 
Percentage (%) composition of components within cinnamon bark and cinnamon 
leaf essential oil after gas chromatography mass spectrometry analysis. 
Component 
Percentage (%) of total 
composition of oil 
Cinnamon 
Bark 
Cinnamon Leaf 
Σ-Cinnamaldehyde 85.312 0.185 
D-limonene 4.665 - 
Eucalyptol 3.823 0.160 
Eugenol 3.366 84.481 
Benzyl benzoate 1.935 2.752 
β-linalool 0.897 1.627 
Caryophyllene - 3.224 
Acetyl eugenol - 2.191 
α-pinene - 0.982 
Camphene - 0.282 
β-terpinene - 0.242 
α-phellandrene - 0.957 
3-carene - 0.04 
Isoterpinolene - 0.062 
m-cymene - 0.638 
2-thujene - 0.201 
p-menth-1-en-8-ol - 0.122 
Copaene - 0.633 
Cinnamyl alcohol acetate - 0.640 
α-caryophyllene - 0.434 
Caryophyllene oxide - 0.141 
Total 99.998 99.994 
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3.3.9 Metabolic activity assay 
Reduction of TTC from a yellow to red colour was observed in microtitre wells 
containing viable P. aeruginosa, but no colour change was observed when 
cells were non-viable (Figure 3.4). Negative control wells with TSB containing 
no bacteria remained clear with no colour change. P. aeruginosa continued to 
show metabolic activity after 10 min of contact time when cinnamon bark EO 
was at 0%, 0.125% and 0.25% (v/v), with some activity after 4 min contact time 
with EO at 0.5% (v/v), but no activity after 6 min. Metabolic activity had ceased 
after 2 min of contact time at concentrations equal or greater to 1% (v/v). 
 
3.3.10 Scanning electron microscopy (SEM) 
Electron micrographs of both untreated and cinnamon bark EO treated P. 
aeruginosa cells are presented in Figures 4.5-4.8. The untreated cells ( 
Figure 3.5 and Figure 3.6) show a turgid structure with a particulate surface 
and are of expected lengths (1 to 5 µm). In contrast, cells treated with 
cinnamon bark EO showed an altered morphology (Figure 3.7 and 
Figure 3.8) with cells appearing collapsed with loss of turgidity and few surface 
particles after 10 min contact time with 2% (v/v) cinnamon bark EO.
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3.3.11 Release of nucleic acids and proteins  
Relative optical densities of filtrate from P. aeruginosa untreated or treated 
with cinnamon bark EO measured at 260 nm and 280 nm are displayed in 
Figure 3.9 and Figure 3.10, respectively. Increased OD260 nm readings signifies 
an increase in nucleic acids, whilst an increase in OD280 nm indicates an 
increase in proteins (Miksusanti et al. 2008) released from bacterial cells. An 
increase was seen in both OD260 nm and OD280 nm when bacteria were treated 
with cinnamon bark EO at either 0.125% or 2% (v/v) when compared to the 
untreated cultures. Release of nucleic acids was significantly different after 
treatment with 0.125% (v/v) EO (P<0.05) and 2% (v/v) EO (P<0.01) when 
compared to untreated bacteria. 
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Figure 3.9 – Nucleic Acid Release Assay 
Relative OD260nm of filtrate from P. aeruginosa control culture, after treatment with 
cinnamon bark EO at 0.125% and 2% (v/v). Control = no EO present; N=3; bars 
showing standard error; asterisk indicates significance. 
 
 
Figure 3.10 – Protein Release Assay 
Relative OD280nm of filtrate from P. aeruginosa control culture, after treatment with 
cinnamon bark EO at 0.125% and 2% (v/v). Control = no EO present; N=3; bars 
showing standard error. 
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3.4 Discussion 
When searching for novel antimicrobials, several different methods can be 
employed to establish the MIC value of an antimicrobial, with more common 
techniques including broth microdilution. When using essential oils (EOs) as 
an antimicrobial, their hydrophobicity often poses a problem when trying to 
disperse them in solutions for dilution. A solvent is often used in antimicrobial 
screening to assist with the dilution of insoluble compounds, and DMSO is a 
frequently chosen solvent in broth dilution methods (Ugur et al. 2016, Oliveira 
et al. 2017, Brahmbhatt et al. 2018, Romulo et al. 2018). The effects of 
solvents on bacterial growth have been investigated in other studies 
(Wadhwani et al. 2012), which found DMSO to be the best solvent when used 
at concentrations of 3% or less compared to methanol or ethanol. The 
suitability of DMSO amongst the Gram-negative and Gram-positive bacteria 
used in this study was assessed. DMSO when used at concentrations <2.5% 
(v/v) had little to no effect on the growth of any organism, with the exception 
of E. coli B (ATCC 23848), which is similar to the findings previously seen in 
the study by Wadhwani et al. (2012). However, in the present study, E. coli B 
(ATCC 23848) in the presence of either concentration of DMSO showed a 
promotion of growth, double that of the control, and produced an unpleasant 
odour after overnight incubation. Similar results were reported by Markarian et 
al. (2002) who found that the growth rate of E. coli in the presence of DMSO 
(1-2% concentration) was almost 4-fold higher than the control. However, 
there was no report of an emitted odour. Following headspace analysis using 
SIFT-MS, it was shown that when E. coli was grown in the presence DMSO, 
DMS was produced at levels 100-fold greater than if grown without. DMS is an 
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organosulphur compound that is ubiquitous in marine environments and 
released by phytoplankton and algae (Todd et al. 2010). DMS is also known 
to have an unpleasant odour (Siebert et al. 2010). DMS has been shown to be 
a product of E. coli in studies looking at DMS production in co-cultured blood 
samples (Umber et al. 2013), and in studies of volatile organic compounds 
produced by inoculated urine samples (Storer et al. 2011). Umber et al. (2013) 
speculate that this DMS production could be a stress related response of E. 
coli in the presence of bactericidal components. However, data from Storer et 
al. (2011), coupled with findings from the present study, suggest that DMS is 
produced without the presence of an antimicrobial compound. Many 
microorganisms use DMSO as a terminal electron acceptor, ultimately 
reducing the compound to DMS through use of a DMSO reductase (De Bont 
et al. 1981), and it has been reported that E. coli possesses several of these 
DMSO reductase enzymes (Sambasivarao et al. 1991). 
Due to the increased growth exhibited by E. coli in the presence of DMSO, 
further investigations were carried out to assess whether DMSO affected EO 
MIC values against this strain. This was determined by the use of an 
alternative method of antimicrobial testing, the agar dilution method, that did 
not use a solvent. It was established that the presence of DMSO did not have 
an effect on results of antimicrobial testing, thus, DMSO was used throughout 
this thesis as a solvent to aid in the homogeneity of essential oils in solutions.  
This chapter continued to examine the effect of EOs against pathogenic 
bacteria, some of which exhibit antimicrobial resistance. Disc diffusion assays 
using EOs at 100% (v/v) concentration demonstrated antimicrobial activity 
against a selected the panel of Gram-positive and Gram-negative bacteria and 
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proved to be a useful screening method to identify EOs that showed 
antimicrobial activity against these organisms. The use of an established 
antibiotic (gentamicin) provided a reference against which the sensitivity of the 
bacteria was assessed, and EUCAST breakpoint tables were used to 
determine expected zones of inhibition (EUCAST 2018). Gentamicin 
sensitivity was observed in all tested bacteria with the exception of MRSA and 
A. baumannii NCTC 12156. Zones of inhibition breakpoints conferring 
resistance for MRSA and A. baumannii treated with gentamicin were >18 mm 
and >17 mm, respectively.  
Following the disc diffusion assay the greatest inhibitory activity was shown 
following exposure to thyme, cinnamon bark and lemongrass. Of these, thyme 
EO was most effective, an observation reported previously by Semeniuc et al. 
(2017) where it was most effective when compared to three other oils. 
Although the MRSA strain used was resistant to gentamicin in this study, 
cinnamon bark, lemongrass, manuka, rosemary and thyme EOs all produced 
zones greater than 18 mm, exceeding the resistance breakpoint of gentamicin 
against this pathogen. A. baumannii NCTC 12156 also showed resistance 
against gentamicin, although tea tree, thyme, rosewood, clove, cinnamon bark 
and cinnamon leaf EOs all produced zones ≥ 17 mm, exceeding the resistance 
breakpoint of gentamicin against this bacteria. These data are in line with 
published reports (Doran et al. 2009, Adukwu et al. 2012, Priti and Shridhar 
2012, Yap et al. 2014, Sakkas et al. 2016), which indicate that EOs are 
capable of working effectively against bacteria resistant to commercial 
antibiotics. However, as pointed out by Jorgensen and Ferraro (2009), whilst 
the disc diffusion method has a place in routine or preliminary testing, the 
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results should be considered more qualitative than quantitative. Thus, further 
testing was carried out to assess the minimum inhibitory (MIC) and minimum 
bactericidal concentrations (MBC) of selected oils which produced the largest 
zones of inhibition. MIC and MBC testing showed that lemon, lemongrass, 
manuka, sweet orange and tea tree EO were more effective against the Gram-
positive bacteria in comparison to the Gram-negative bacteria. Lemongrass 
and manuka in particular were shown to have lower MICs/MBCs for S. aureus 
when compared to other bacteria tested. These findings are in agreement with 
studies that found manuka EO to be more effective against S. aureus 
compared to E. coli and P. aeruginosa (Porter and Wilkins 1998), and studies 
where lemongrass EO also showed good effect against Gram-positive 
bacteria (Hammer et al. 1999). In the present study, cinnamon bark at very 
low concentrations (i.e. 0.015% v/v), was bactericidal against MRSA, which is 
supported by Cui et al. (2016) where cinnamon oil was found to be bactericidal 
against MRSA at 0.25 mg mL-1, approximately 0.025% (v/v).  
Cinnamon leaf, clove, lemongrass, rosewood and thyme oils at <4% (v/v) were 
bactericidal against all the bacteria, excluding Pseudomonas species. This is 
in agreement with a study by Kavanaugh and Ribbeck (2012), who reported 
that clove, thyme and tea tree EO were not bactericidal against Pseudomonas 
spp. at concentrations less than or equal to 4% (v/v). 
Other studies have shown that EOs are more effective against Gram-positive 
bacteria (Lodhia et al. 2009), which is supported by some of the results 
presented here. However, equal or greater efficacy was observed when the 
Gram-negative bacteria were treated with some of the oils. Bergamot, 
cinnamon bark, cinnamon leaf, clove, grapefruit, lime, rose geranium and 
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rosewood EOs all produced greater zones of inhibition in some Gram-negative 
bacteria compared to zones produced for Gram-positive bacteria. Of the oils 
tested for MIC, cinnamon leaf, clove, rosewood, tea tree and thyme had lower 
or equal MIC for Gram-negative bacteria. Cinnamon bark EO demonstrated 
bactericidal effects against all the strains used in this study at very low 
concentrations (i.e. ≤ 0.25% v/v).  
When comparing the oils to justify further testing, disc diffusion testing 
indicated that cinnamon bark, lemongrass and thyme were most effective 
overall, exhibiting the largest zones of inhibition on average. When looking at 
MIC and MBC testing, again cinnamon bark and thyme were similar in their 
efficacy. However, whilst both cinnamon bark and thyme exhibited broad 
spectrum activity and efficacy at low concentrations, only cinnamon bark EO 
was effective against Pseudomonas spp. at concentrations of <4% (v/v). 
Therefore, cinnamon bark EO was selected for further investigations to identify 
its capability of rapid bactericidal activity and its possible mode of action.  
GC-MS analysis showed that the major component of cinnamon leaf oil used 
in this study was eugenol, which was 84.5% of the total oil composition, a 
similar finding to other published studies (Mallavarapu et al. 1995, 
Paranagama et al. 2001, Raina et al. 2001, Jayawardena and Smith 2010). In 
contrast, the major component of the cinnamon bark oil used in this study was 
Σ-cinnamaldehyde at 85.3% of the total composition. The high levels of this 
component in the bark EO has been demonstrated elsewhere in other studies 
(Paranagama et al. 2001, Jayawardena and Smith 2010, Shahina et al. 2018). 
This contrasting composition of the two oils provides an explanation of their 
different effects as antimicrobials, as it has been shown that cinnamaldehyde 
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has a superior antimicrobial effect when compared to eugenol (López et al. 
2007, Sanla-Ead et al. 2011, Brnawi et al. 2018). The differences seen in oil 
composition also highlight the importance of adequate analysis of EOs, using 
methods such as GC-MS, to confirm the origin of the oil and identify which part 
of the plant it is derived from. This is especially important in the instance that 
oils supplied are incorrectly identified by the supplier, as is what happened 
with the oils described in section 2.3.  
From the time-kill assay conducted in this study, cinnamon bark EO exhibited 
bactericidal effects with rapid killing action (three-log reduction) at ≤30 min at 
concentrations ≥0.25% (v/v). The TTC assay was used to indicate the 
presence or absence of metabolically active cells which would convert TTC to 
a coloured formazan derivative (Sabaeifard et al. 2014). The results obtained 
correlate well with the time-kill assay, however, it has been reported that TTC 
reduction may not correlate exactly with MIC, and end-points are less easily 
determined using the TTC assay when compared to that of other redox 
indicators, such as resazurin (Mann and Markham 1998). 
The bactericidal effect of cinnamon bark EO on P. aeruginosa cell morphology 
was examined by scanning electron microscopy (SEM). After only 10 min of 
exposure to the EO, morphological changes to the treated cells were 
pronounced, and suggested total cell collapse, loss of turgor and likely loss of 
viability. Reports on the mechanism of action of EOs suggest their role in the 
destruction of the cell wall, damage to the cytoplasmic membrane and 
membrane proteins, and cell leakage (Goldbeck et al. 2014). This suggestion 
is supported by data from the membrane permeability assay, which indicate 
that cinnamon bark EO causes leakage of nucleic acids, a probable result of 
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a compromised cell membrane. This is in agreement with Bouhdid et al. (2010) 
who found that cinnamon bark oil affected the membrane of P. aeruginosa 
which ultimately led to cell death. This contrasts however, with the findings by 
Cox and Markham (2007) and Helander et al. (2000) who showed that Σ-
cinnamaldehyde, a predominant component of the cinnamon bark EO used in 
this study, did not have an effect on the membrane of P. aeruginosa and was 
deemed to not be a pore forming compound. This highlights the importance of 
using whole oils, and not their isolated compounds, as it may not reflect the 
antimicrobial capability of an oil. It also further highlights the need for oil 
analysis to identify the blend of different compounds present and the role they 
play in the antimicrobial effects of an EO.  
Cinnamon EO is sourced from either the bark or the leaf of the plants (Park et 
al. 2018), with the EO extracted from bark most often investigated for its 
antimicrobial activity (Nabavi et al. 2015). Cinnamon bark EO is already well 
described for its antimicrobial activity (Manso et al. 2014, Wu et al. 2015, Wen 
et al. 2016, Zhang et al. 2016, Chouhan et al. 2017), and shown to be highly 
bactericidal against Pseudomonas spp. (Utchariyakiat et al. 2016). However, 
to our knowledge, the present study is the first to demonstrate the rapid killing 
effect of the oil against P. aeruginosa, with contact times of <30 min.  
Although 4% (v/v) was the highest concentration tested, and the maximum 
concentration recommended by the manufacturer for topical use, cinnamon oil 
is widely reported to be “Generally Regarded/Recognised as Safe” (GRAS) 
(Tzortzakis 2008, Xing et al. 2011, Ojagh et al. 2014, Cui et al. 2016, Bravo 
Cadena et al. 2018). As of May 2019, the Food and Drug Administration (FDA) 
consider cinnamon bark EO, from either C. zeylanicum, C. cassia or C. loureirii  
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to be GRAS (FDA 2019). A study by Adams et al. (2004) further supported the 
GRAS status of cinnamon oil after investigating the toxicity of 55 cinnamyl 
derivatives commonly found in cinnamon oil, used as flavouring agents, and 
determining them to be GRAS. Whilst toxicity testing for cinnamon oil is limited, 
Ranasinghe et al. (2012) report that preclinical in vivo studies are yet to show 
significant toxic effects but acknowledge that more clinical trials are needed to 
further understand the therapeutic safety of cinnamon in humans. Also, many 
of the studies that investigate toxicity of “cinnamon” in mouse or rat models 
are in fact testing the pure cinnamaldehyde component (Jenner et al. 1964, 
Hébert et al. 1994, Adams et al. 2004). However, cinnamon oil is recognised 
as a skin irritant (Veal 1996). Several case reports of contact dermatitis were 
described by Connolly et al. (2017), although patients in this report were 
subsequently patch tested for allergies and were all confirmed to be sensitive 
to cinnamaldehyde or other related compounds. A study by Bickers et al. 
(2005) reported that cinnamaldehyde below a concentration of 1.25% will not 
cause primary irritation, though it will be an irritant at concentrations greater 
than 3%. With these reports in mind, safety regarding the use of these natural 
compounds is a potential issue and risks must be recognised when contact 
with humans (and other animals) occurs. However, as previously described, 
antimicrobial effects of cinnamon bark oil seen in this study have been evident 
at concentrations as low as 0.015% (v/v) and effective concentrations 
throughout MIC testing do not exceed 0.25% (v/v). Furthermore, the intended 
use of the EO reported in this study is not directly associated with oral or 
dermal contact in humans. Contact would be the same as with any other 
antimicrobial disinfectant or sanitiser, and so toxicity of cinnamon EO does not 
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pose the same risks as those reported in case studies regarding adverse 
reactions (Bickers et al. 2005).  
EOs have thus far shown their potential as antimicrobials, though their real-
world application is not limited to this function. EOs have been used as 
antimicrobials, flavourings and fragrances in aromatherapy, medicine, 
industrial food and drink production and the cosmetic industry (Baser and 
Buchbauer 2015).  
In summary, the preliminary experiments investigating DMSO highlighted the 
importance of investigating solvents that are used to disperse EOs, which may 
have an effect on results during antimicrobial screening. Growth promotion in 
antimicrobial testing may lead to inoculum effect, causing significant increases 
in MIC (Brook 1989), which would be detrimental to novel antimicrobial 
screening, however in this instance DMSO did not have an effect on MIC 
values. This chapter has also investigated the possible volatile organic 
compounds that microorganisms may produce in the presence of solvents. 
Further investigation of these compounds in the headspace of cultures 
supplemented with solvents, and additional work to fully refine the SIFT-MS 
analysis, is required. However, despite these limitations, this study highlights 
the potential of this technique for the rapid identification of volatile compounds 
in microbial cultures. 
This chapter has shown that EOs are effective antimicrobial agents and many 
possess broad-spectrum activity. Cinnamon bark EO in particular has 
demonstrated strong bacteriostatic and bactericidal action against P. 
aeruginosa. This provides a sound basis for further work to explore the use of 
 82 
cinnamon bark EO as an alternative to conventional antimicrobial products 
owing to its fast-acting bactericidal properties at low concentrations.  
The work presents in this chapter has confirmed that cinnamon bark is an 
antimicrobial EO which provides broad spectrum, high bactericidal activity 
when used at low concentrations and within a short contact time. These 
qualities make it an ideal candidate as an alternative to current antimicrobials, 
for example on surfaces in clinical and food preparation applications, in 
disinfection and infection control. Many studies investigating time kill and 
bactericidal activity of EOs expose bacteria to longer contact times, though it 
is important that shorter contact times are investigated, and this study 
highlights the importance of performing antimicrobial tests using contact times 
<10 min. Findings from this study further support the reports that the mode of 
action of cinnamon bark EO against P. aeruginosa is due to effects on the 
membrane of the bacteria, leading to cell leakage and cell death, shown here 
by of SEM and membrane permeability assays. Although EOs are generally 
recognised as safe (GRAS) by the Food and Drugs Administration (FDA), 
including that of cinnamon (Maisanaba et al. 2017), more investigation is 
needed to assess cinnamon EO’s application to control bacterial pathogens 
and subsequent interaction with humans. This study also highlights the 
importance of analysing these natural products before use, in order to 
determine their composition and to identify their key components. The 
composition and antimicrobial diversity observed amongst oils originating from 
different parts of the same species of plant emphasises the need for batch 
control and consistency when developing these oils for antimicrobial purposes. 
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CHAPTER 4 
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4 GROWTH OF BACTERIAL BIOFILMS AND TREATMENT OF 
PSEUDOMONAS AERUGINOSA BIOFILMS WITH 
CINNAMON BARK EO IN LIQUID PHASE 
 
4.1 Introduction 
An important feature of Pseudomonas is its ability to form and exist as robust, 
protective biofilms which aids in its survival and resistance to antimicrobials 
(Sabaeifard et al. 2014). Biofilm formation is often thought to be the primary 
underlying cause for the failure of an antimicrobial agent, with 65-80% of all 
infections believed to be biofilm-related (Coenye and Nelis 2010). Cells 
existing as a biofilm often have an increased resistance to antimicrobial agents 
of up to 10–1000 times, with multiple mechanisms of resistance recognised 
within a single community (Mah and O’Toole 2001). The resistance to 
antimicrobials shown by bacteria in biofilms can be explained by the failure of 
the antimicrobial agent to penetrate the biofilm, largely due to the presence of 
an exopolysaccharide matrix (EPS) that is secreted when the biofilm is 
maturing (Butt and Khan 2015). Difficulty to treat biofilms, their increased 
resistance and their significance in current infections, indicates a necessity to 
develop new ways to combat them. The antimicrobial activity of many EOs, 
including that of cinnamon EO against Pseudomonas spp., has been 
investigated previously and some studies, including this thesis, have shown 
that cinnamon bark EO has good antibacterial activity (Bouhdid et al. 2010, 
Utchariyakiat et al. 2016). However, these studies did not assess the effects 
of cinnamon bark EO against Pseudomonas biofilms. Where the effect of EOs 
on biofilms have been studied using alternative EOs and biofilm bacteria (Kalia 
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et al. 2015, Kim et al. 2015), different concentrations and contact times 
typically have not been investigated. Thus, the aims of experiments reported 
in this chapter were to elucidate the anti-biofilm effects of cinnamon bark EO 
in liquid state, against P. aeruginosa biofilms grown on different surfaces, and 
to establish an optimum concentration and contact time.  
 
4.1.1 Chapter progression 
The following flow diagram depicts a summary of the progression of this 
chapter. 
 
 
 
Assess biofilm forming 
capabilities
- Use of microtitre plate assay to evaluate biofilm adherence strength of 
bacteria
Initial anti-biofilm testing
- Use of microtitre plate assay to ascertain minimum biofilm inhibition 
concentration (MBIC) and minimum biofilm eradication concentration 
(MBEC) for cinnamon bark EO against P. aeruginosa biofilms
Use of CBR and 24 h direct 
treatment
- Use of CDC biofilm reactor (CBR) for in vitro growth of biofilms 
different surfaces 
- Exposure of biofilms to cinnamon bark EO in liquid state at different 
concentrations for 24 h 
Extended testing
- Decreased exposure time of biofilms to cinnamon bark EO to evaluate 
influence of contact time on anti-biofilm activity 
 86 
4.2 Methods 
4.2.1 Crystal violet (CV) biofilm assay 
CV biofilm assay was carried out as described in section 2.4.1.  
 
4.2.2 Minimum biofilm inhibition concentration (MBIC) 
Methods to assess MBIC concentration were adapted from Stepanović et al. 
(2000) and Adukwu et al. (2012) and were similar to methods described in 
section 2.4.1. An overnight culture of P. aeruginosa was standardised to ~1.5 
x 108 CFU mL-1 as described in section 2.2, with the exception of being diluted 
with TSB medium supplemented with 1% (v/v) glucose. One hundred 
microliters of this suspension were added to each well of a 96-well microtitre 
plate, in addition to 100 µL of TSB containing cinnamon bark EO 
concentrations, ranging from 0.015% to 2% (v/v) (prepared as described in 
section 2.3.2). Negative controls contained no EO. Plates were incubated at 
37°C for 24 h. Then each well was carefully aspirated and washed three times 
using 250 µl of sterile phosphate buffered saline (PBS). Bacteria were fixed 
using 200 µL of methanol for 15 min, wells were emptied and then air dried. 
After air drying, wells were stained with 250 µL of 0.1% crystal violet for 5 min. 
Excess stain was removed by rinsing with tap water. After leaving to air dry, 
the bound stain was solubilised with 250 µl of 33% (v/v) acetic acid. The optical 
density (OD) of wells in the plate was then read using a TECAN Infinite® 200 
PRO plate reader at 595 nm. Absorbance values of oil dilutions were 
subtracted from OD values to correct for turbidity exhibited by oils. Inhibition 
of biofilm growth was indicated if the OD was less than or equal to the OD cut-
off (ODc), defined as three standard deviations above the mean OD of the 
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negative control. Three wells were used per EO concentration and the 
experiment was independently carried out in triplicate.   
 
4.2.3 Minimum biofilm eradication concentration (MBEC) 
Methods for assessing MBEC were adapted from Malic et al. (2013). Briefly, 
wells of a 24-well microtitre plate were filled with 1 mL of overnight culture that 
was standardised to ~1.5 x 108 CFU mL-1, as described in section 2.2, with the 
exception of being diluted with TSB medium supplemented with 1% (v/v) 
glucose. Plates were incubated at 37°C for 24 h. Next, the medium was 
removed gently using a pipette and wells were washed with 1 mL of PBS. EO 
dilutions were prepared as described in section 2.3.2 and 1 mL of each EO 
was added to separate biofilms wells. Plates were incubated for a further 24 h 
at 37°C. The medium again was removed gently by aspiration and wells were 
washed with PBS. One millilitre of TSB was added to each biofilm, followed by 
disruption via repeated agitation with a pipette. Aliquots (100 µL) of each well 
were plated onto MHA in triplicate and incubated at 37°C for 24 h and 
observed for growth. The same 24 well plates were incubated for a further 6 h 
under the same conditions as before and aliquots were removed and plated 
after this time, to assess bacterial viability. MBEC was defined as the lowest 
concentration of EO capable of preventing regrowth after subsequent 6 h 
incubation step. Three independent experiments were carried out in triplicate. 
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4.2.4 Growth of P. aeruginosa biofilms in the Centre for Disease Control 
biofilm reactor (CBR) 
Standardised 48 h mature P. aeruginosa PAO1 biofilms were grown on 
polycarbonate (PC) or stainless steel 316L (SS) coupons using the CBR as 
described in section 2.4.2. 
 
4.2.5 Essential oil 
Cinnamon bark EO was used as described in section 2.3. 
 
4.2.6 Direct treatment of biofilms grown in CBR 
A schematic of this method is demonstrated in Figure 4.1. Dilutions of 
cinnamon EO were made in 30 mL TSB to achieve concentrations of 2%, 0.2% 
and 0.02% (v/v), with DMSO used as a solvent at concentrations of 1.25%, 
0.125% and 0.0125% (v/v), respectively. A control was used for each 
treatment with only TSB and DMSO at respective concentrations. Rods from 
the CBR holding mature biofilms, on either PC or SS coupons were removed 
from the reactor, rinsed with sterile phosphate buffered saline (PBS) and 
placed into the TSB containing cinnamon bark EO, previously described. Rods 
were removed from the treatment after 24 h of contact. In some cases, further 
testing at 5, 10, 30, 60 min and 6 and 12 h was carried out. After removal from 
treatment, rods were rinsed in sterile PBS and each coupon released into 10 
mL of TSB, sonicated for 10 min and vortexed for 30 s. The disaggregated 
biofilms were diluted serially and plated onto MHA and incubated at 37°C for 
24 h. The CFU mL-1 from three coupons were enumerated for each condition 
per experiment and the experiment was repeated in triplicate. Results were 
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expressed as mean log CFU mL-1. When 10-0 dilution was plated, limit of 
detection was 10 CFU mL-1. 
 
4.2.7 Data analysis  
Two-Way ANOVA and comparison of column factors was used to assess 
significant differences between treatments and controls following direct 
treatment of biofilms.  
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4.3 Results 
4.3.1 CV biofilm assay  
Results of the CV biofilm assay are demonstrated in Table 4.1. All bacteria 
tested were capable of forming biofilms, and categorised as either moderate 
or strong biofilm formers, with the exception of A. baumannii ATCC 17978 
which was classified as weak. 
 
 
Table 4.1 – Biofilm Adherence Testing 
Classification of biofilm adherence of various bacterial strains following the crystal 
violet biofilm assay. N=3 
Organism 
Absorbance 
(OD595) 
Adherence 
Negative control  0.082 N/A 
Escherichia coli ATCC 23848 (B strain) 0.244 Moderate 
Escherichia coli NCTC 9001 0.108  Weak 
Staphylococcus aureus ATCC 6358 0.887  Strong 
Staphylococcus aureus NCTC 12981 3.903 Strong 
Hospital Acquired MRSA isolate 1.460  Strong 
MSSA NCTC 13297 1.664  Strong 
Acinetobacter baumannii NCTC 12156 0.617  Strong 
Acinetobacter baumannii ATCC 17978 0.629  Strong 
Pseudomonas aeruginosa (PAO1) 3.920  Strong 
Pseudomonas aeruginosa NCTC 8505 2.641  Strong 
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4.3.2 MBIC and MBEC 
Results from MBIC testing and a summary of results from MBIC and MBEC 
testing can be seen in Table 4.2 and Table 4.3, respectively. P. aeruginosa 
(PAO1) biofilms grown in the presence of EO concentrations greater than or 
equal to 0.12% (v/v) were categorised as non-adherent, biofilms grown in the 
presence of 0.06% (v/v) EO were moderately adherent, and biofilms grown in 
the presence of EO concentration less than or equal to 0.03% (v/v) were 
strongly adherent. Thus, the minimum concentration of cinnamon bark EO 
which effectively inhibited the growth of P. aeruginosa biofilm was determined 
to be 0.12% (v/v). Preformed biofilms treated with cinnamon EO were 
effectively removed when treated with EO concentrations greater than or equal 
to 1% (v/v). However, when treated biofilms were provided with fresh medium, 
bacterial viability was evident after 6 h of further incubation in biofilms treated 
with 1% (v/v) EO. No regrowth was seen in biofilms that were treated with 2% 
(v/v) EO. Therefore, the minimum concentration of cinnamon bark EO which 
effectively eradicated preformed P. aeruginosa biofilms, with no regrowth after 
further incubation in fresh medium, is 2% (v/v).  
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Table 4.2 – Minimum Biofilm Inhibition Concentration Testing 
Classification of biofilm adherence of P. aeruginosa PAO1 in the presence of 
cinnamon bark essential oil. N=3 
Concentration of cinnamon bark EO 
Absorbance 
(OD595)* 
Adherence 
Negative control  0.054 N/A 
4% 0.000 Non-adherent 
2% 0.014 Non-adherent 
1% 0.038 Non-adherent 
0.5% 0.026 Non-adherent 
0.25% 0.022 Non-adherent 
0.125% 0.034 Non-adherent 
0.06% 0.195 Moderate 
0.03% 0.915 Strong 
0% 2.219 Strong 
* Values corrected to subtract absorbance values of oil dilutions 
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4.3.3 Direct treatment of biofilms on polycarbonate (PC) 
Results of treating P. aeruginosa biofilms grown on PC coupons with 
cinnamon bark EO in liquid state is shown in Figure 4.2, Figure 4.3 and Figure 
4.4. After 24 h of contact time, treatment with 0.02% (v/v) had no significant 
effect on biofilms (P>0.05), however, biofilms treated with either 0.2% (v/v) or 
2% (v/v) were significantly reduced after 24 h of treatment (P<0.0001). 
Treatment with 0.2% (v/v) resulted in a 5.22 log reduction of viable bacteria 
whereas 2% (v/v) resulted in 8 log reduction and complete eradication of 
biofilm (100% reduction). Further testing for 0.2% and 2% (v/v) treatment 
included 10, 30 and 60 min, and 6 and 12 h contact times (Figure 4.3 and 
Figure 4.4). After 10, 30 and 60 min exposure to 0.2% (v/v), less than 2 log 
reduction in CFU mL-1 was observed in biofilms grown on PC coupons. After 
6 h and 12 h, 3.39 and 3.84 log reductions were observed, respectively. 
Exposure to 2% (v/v) again produced 100% reduction after only 10 min contact 
time and this was maintained across all further contact times (Figure 4.4). 
Table 4.3 – Biofilm Inhibition and Eradication Testing 
Minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication 
concentration (MBEC) values for cinnamon bark EO against P. aeruginosa PAO1 
 Cinnamon bark EO concentration (v/v) 
MBIC 0.12% 
MBEC 2% 
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Further testing for 2% (v/v) treatment included a shorter 5 min contact time 
and a 3 log reduction was observed (Figure 4.4).  
 
4.3.4 Direct treatment of biofilms on stainless steel (SS) 
Results of P. aeruginosa biofilms grown on SS coupons treated with cinnamon 
bark EO in liquid state are shown in Figure 4.2 and Figure 4.5. After 24 h of 
contact time, treatment with 0.02% (v/v) had no significant effect on biofilms 
(P>0.05). Biofilms treated with 0.2% (v/v) for 24 h were significantly reduced 
by 3.9 log (P ≤ 0.0001), and biofilms treated with 2% (v/v) for 24 h were 
significantly reduced by 4.19 log (P<0.001). Further testing for 2% (v/v) 
treatment included 10, 30 and 60 min, and 6 and 12 h contact times. A 3.28, 
3.34 and 3.34 log reduction was observed in biofilms treated with 0.2% (v/v) 
for 10, 30 and 60 min, respectively, and 4.45 and 4.46 log reductions were 
observed, after 6 h and 12 h, respectively. Log reductions after 10 min, 60 min 
and 6 h were significantly different from the control (P<0.0001), as were log 
reductions after 30 min and 12 h (P<0.001). 
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4.4 Discussion 
Due to the importance of the role of biofilms in AMR, this chapter aimed to 
investigate the biofilm forming capabilities of several species of bacteria and 
assess the anti-biofilm activity of cinnamon bark EO. Investigations began with 
an assessment of adherence using the crystal violet (CV) biofilm assay. The 
CV biofilm assay can be considered to be a semi-quantitative method and 
useful as a comparative tool to classify biofilm production (Di Domenico et al. 
2016). Although the previous chapter focused on the effects of cinnamon bark 
EO against P. aeruginosa PAO1, the other species and/or strains of bacteria 
previously used were also included in the CV biofilm assay in this chapter. This 
was because P. aeruginosa is a known biofilm former, therefore the CV biofilm 
assay employed in this study not only confirmed this for the PAO1 strain, but 
also compared it to the other strain of P. aeruginosa and other species of 
bacteria used earlier in this study. Although all of the bacteria assessed in this 
chapter were capable of forming biofilms of varying strength, the knowledge 
that P. aeruginosa PAO1 formed strongly-adherent biofilms, coupled with 
previous findings from chapter 4 and 5 showing Pseudomonas to be the least 
tolerant to essential oils, justified the continued testing to assess anti-biofilm 
properties of cinnamon EO against only Pseudomonas biofilms. Use of the CV 
biofilm assay has its strengths and weaknesses for assessing biofilms and 
their treatment. Some of the main strengths of the CV biofilm assay are its 
simplicity, low cost, and ability to rapidly assess multiple samples at the same 
time (Wilson et al. 2017). The main disadvantage is that CV is a positively 
charged dye which will stain the surface of any negatively charged molecules, 
including the polysaccharide extracellular matrix of bacteria (Petrachi et al. 
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2017). Thus the assay indicates the amount of biomass that is left behind 
regardless of whether cells are living or dead (Pantanella et al. 2013). 
Nevertheless, the initial use of multi-well plates for biofilm growth provided a 
reliable high-throughput assay method for testing the biofilm forming 
capabilities of the bacteria used in this study.  
The microtitre plate method of biofilm growth is a frequently used closed 
system model of growth (Macià et al. 2014), which can be easily adapted for 
anti-biofilm testing. However, it also comes with advantages and 
disadvantages similar to those of the CV biofilm assay. Using the microtitre 
plate biofilms for antimicrobial testing gives the user the ability to test multiple 
species, several treatments and/or growth conditions, changes in temperature 
and humidity, or all of the above, at the same time (Coenye and Nelis 2010).  
Unfortunately, its closed system with no inward or outward flow means that 
uncontrolled changes will happen to the environment within the wells of the 
plate, including nutrient depletion, oxygen limitation, accumulation of 
metabolites or other molecules, and interference from planktonic cells (Merritt 
et al. 2011, Lüdecke et al. 2014, Macià et al. 2014, Azeredo et al. 2017). 
Despite these downfalls, this method was used first in this chapter to gain a 
preliminary understanding of the concentrations that might be required for later 
testing against biofilms.  
The MBIC of cinnamon bark EO was determined as 0.12% (v/v), which is the 
same as the minimum inhibitory concentration of this EO against planktonic 
cells of this bacterium (chapter 3). This is similar to the data of Firmino et al. 
(2018), who found that cinnamon oil as low as 0.12 mg mL-1, approximately 
0.012% (v/v), reduced biofilm growth of P. aeruginosa after 24 h of culture 
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when assessing biomass, and 1.92 mg mL-1, approximately 0.192% (v/v), 
prevented biofilm growth entirely.  
With regards to MBEC methods in this study, the use of subculturing allowed 
an estimation of the viability of the bacteria following exposure to the EO. 
Methods used in this chapter employed a further 6 h incubation in fresh 
medium, however the duration of re-incubation could have been improved to 
better reflect real-time generation of Pseudomonas biofilms. Pericolini et al. 
(2018) report that whilst the generation time for P. aeruginosa PAO1 is less 
than 30 min, the maximum biofilm biomass is reached after 24 h incubation. 
Therefore, to ensure that a biofilm has been truly eradicated and unable to re-
establish as a biofilm, a longer re-incubation time would be required following 
treatment. However, further incubation for 6 h, as was used here, can be used 
to comment on whether or not viable bacteria remain. These bacteria then 
have the potential to re-establish a biofilm.  
Results from this chapter revealed that whilst 1% (v/v) EO was able to remove 
preformed P. aeruginosa biofilms, the remaining bacteria were viable and able 
to recover after further incubation with fresh media. Thus, the MBIC of 
cinnamon bark EO was determined as 2% (v/v) when used to treat P. 
aeruginosa PAO1 biofilms.  
CFU counts are a simple and effective indicator of viability, more robust and 
thorough testing could be performed to give a definitive indication of viability. 
It has been reported that methods for assessing viability should take into 
consideration the method of antimicrobial testing, and ideally a combination of 
these methods could be utilised (Cai et al. 2014). These include indirect 
methods requiring further culturing or reactions, such as the CFU 
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determination or detection of metabolic activity using stains and indicators, or 
direct methods which use molecular probes such as the BacLightTM Live/Dead 
stain kit (Cai et al. 2014).  Whilst using these methods might be preferable, 
they were deemed unnecessary for the present study. This is because, 
although valuable, the use of microtitre plates for biofilm growth is not relatable 
to naturally occurring biofilms due to many of the disadvantages covered 
earlier. To address this, the anti-biofilm activity of cinnamon EO was 
investigated further using the CDC biofilm reactor (CBR).  
The CBR was developed by Donlan et al. (2002) to provide a biofilm model 
that operates as a continuous-flow stirred tank reactor. Holders within the 
reactor are capable of accommodating 24 coupons, made of any chosen 
material, on which bacteria will attach and form biofilms. The reactor sits upon 
a stir plate, which can provide heat if required, and generates a shear force 
across the surface of the coupons by way of a magnetic baffle. Rigorous 
statistical assessments of the reactor ruggedness and repeatability have been 
examined by Goeres et al. (Goeres et al. 2005) who found that the CBR is a 
reliable model for biofilm growth and a useful tool in answering diverse 
research questions regarding biofilms. In fact, the recently produced American 
standards for biofilm disinfection uses the CBR as the primary growth model 
(Environmental Protection Agency 2017). Buckingham-Meyer et al. (2007) 
highlight the importance of choosing a biofilm model that will closely replicate 
the natural environment that the test bacteria typically are associated with, 
where several factors including shear force will create diverse and dynamic 
growth conditions.  
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P. aeruginosa is ubiquitous in the environment and commonly found in water, 
soil or associated with animals (Fazeli et al. 2012). This organism has been 
synonymous with hospital acquired infections for over 50 years and evidence 
has shown that hospital water plumbing networks are implicated in these 
endemic outbreaks (Quick et al. 2014).  P. aeruginosa are regularly found in 
hospital water samples (Asghari et al. 2013) and generally harboured in and 
on water-related sites such as taps, sinks, showers, ice makers, mop heads 
and buckets, hydrotherapy pools and bath toys (Kerr and Snelling 2009, 
Aspelund et al. 2016, Bédard et al. 2016, Lalancette et al. 2017). This is 
evidence that Pseudomonas biofilms are likely to thrive in conditions where 
they are subjected to shear forces and continuous flow, and thus the CBR is 
ideal for use as a growth model to study this organism. It has been shown that 
biofilms grown using the CBR are not as easily removed compared to other 
models (Buckingham-Meyer et al. 2007) but that CBR biofilms are better 
models for removal with good relevance to industrial or clinical settings 
(Shelobolina et al. 2018).  
Testing using the CBR provided evidence of the inefficiency of cinnamon bark 
EO to reduce PAO1 biofilms at very low concentrations (i.e. 0.02% v/v), when 
in liquid state, and showed cinnamon EO was unable to significantly reduce 
biofilms grown on either PC or SS surfaces at this concentration. This is a 
reasonable finding considering results from the MBEC testing performed 
earlier. However, this study demonstrated that low concentrations of cinnamon 
EO (i.e. 0.2% v/v) were capable of producing at least 3 log reduction in biofilms 
grown on either PC or SS after 24 h of contact time.  
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This reduction in biofilms is not only significant statistically (P<0.001) but also 
significant when considering cinnamon EO as a potential disinfectant in situ. 
Disinfection protocols are  deployed routinely in the prevention and reduction 
of infection spread (Muniesa et al. 2019) and should conform to standards 
such as the British Standards European Norm (BS EN). Currently, only the 
United States Environmental Protection Agency (EPA) have published 
standardized protocols for anti-biofilm efficacy testing, and there are no 
European standards in this area (Ledwoch et al. 2019). Therefore, new 
disinfectants developed within the UK rely on the BS EN standards 1276 and 
13697 for suspension and surface disinfection, though these are relative to 
planktonic state bacteria only. Consequently, if these standards are to be used 
as a benchmark for anti-biofilm efficacy then contact time should be 5 min and 
log reduction in CFU should exceed 5 (British Standards Institution 2009, 
2015). In 2017 the EPA became the first agency to offer methods and 
guidance in combatting biofilms growing on hard non-porous surfaces, and 
recommended that a successful product should reduce biofilms by at least 6 
log CFU, with a minimum starting bacterial load of 8 log CFU, and a contact 
time not exceeding 10 min (Environmental Protection Agency 2017). Whilst 
investigating the anti-biofilm effects of cinnamon bark EO within this chapter, 
both of these standards were considered when evaluating successes and/or 
failures of cinnamon bark EO.  
Further testing to investigate 2% (v/v) EO proved the oil to be even more 
effective and showed that cinnamon EO was able to cause significant 
reduction of biofilms within 5 and 10 min when grown on PC and SS, 
respectively. When grown on PC coupons, biofilms exposed to 2% (v/v) EO 
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were reduced by 3.02 log CFU mL-1 after 5 min of contact time (P<0.001). 
Following exposure to the EO for 10 min or more, biofilms on PC coupons 
were reduced completely and no viable bacteria were seen in further 
cultivation steps (P<0.001). In contrast to this, biofilms grown on SS coupons 
remained viable after all durations of exposure to 2% (v/v) EO. After 10 min 
contact time, a 3.28 log reduction in CFU mL-1 (P<0.001) was observed. 
Despite further reduction as duration of treatment increased, after 24 h of 
contact time ~44% of bacteria remained viable on the coupon, compared to 
that of 0% viable bacteria on PC coupon biofilms tested in comparable 
conditions.  
In the previous chapter it was noted that the toxicity of cinnamon bark oil would 
need to be taken into consideration when evaluating its uses. In this chapter, 
cinnamon oil at 2% was highly effective, which is lower than the described 
concentration that could cause skin irritation (Bickers et al. 2005), thus 
providing promise in its use which could potentially lead to contact with human 
skin.  
The present study grew biofilms on two different surfaces, polycarbonate 
plastic (PC) and 316L stainless steel (SS).  Both of these materials are 
commonly used surface materials, especially in hospital environments 
(Schmidt et al. 2012). Saka et al. (2017) report that microbial pathogens can 
survive for extended periods of time on both SS and polymeric materials. The 
present study has indicated that cinnamon EO appeared to be more effective 
at reducing biofilms when they were grown on PC as opposed to SS coupons. 
This may be explained by a difference in surface attachment between biofilms 
on PC and SS. Results from the study by Abdallah et al.  (2014), indicate that 
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when  P. aeruginosa was grown on SS, the adhesion rate was double that of 
biofilms grown on PC. This is possibly connected to surface smoothness, as 
a rougher surface could play a role in adhesion by offering protection against 
shear forces (Barnes et al. 1999). Baker (1984) also found that when 
investigating bacterial attachment in rivers, roughened substrates were 
colonised significantly faster than the smoother surfaces. Baker speculates if 
this is due to rougher surfaces providing protection, but also suggests that 
roughened surfaces would have an increased surface area, providing a larger 
area for colonization. A study by Holah and Thorpe (1990) used scanning 
electron microscopy to assess the surface roughness of both PC and SS 
surfaces, and found untampered PC to be the smoothest. These reports 
corroborate findings from this study and emphasize the importance of surface 
of growth when testing antimicrobial efficacy against biofilms.  
In conclusion, this study aimed to address the question of how effective 
cinnamon bark EO is against P. aeruginosa biofilms. Preliminary biofilm 
models utilised microtitre plates for high-throughput and multiple treatment 
environments. This found the MBIC to be a low concentration of 0.125% (v/v) 
and showed an MBEC of 2% (v/v). Continuing from these tests, the CBR was 
employed to produce robust mature biofilms which more closely reflected 
those that are naturally occurring. The anti-biofilm effects of cinnamon bark 
EO were tested against biofilms grown on either PC plastic or SS surfaces, 
mimicking surfaces commonly found in both industrial and healthcare settings. 
Cinnamon bark EO at 2% (v/v) proved to be the most effective, especially 
against biofilms grown on PC coupons, and successfully reduced these 
biofilms by 100% after 10 min of contact time. A 5 min contact time of 2% (v/v) 
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EO against biofilms on PC also reduced biofilms by 3 log CFU mL-1. It was 
shown that cinnamon bark EO was more effective against biofilms grown on 
PC versus SS and this could be explained by the microscopic differences 
between these two surfaces and how bacteria may interact with them. If US 
standards for anti-biofilm activity are used to evaluate the findings from this 
study, then cinnamon bark EO is an eligible product for biofilm disinfection, 
producing a greater than 6 log reduction within 10 min of contact time. 
Nonetheless, it is evident that European standards need to be reviewed and 
updated to include the growth of bacteria as biofilms that are ubiquitous in the 
environment.  
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CHAPTER 5 
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5 VAPOUR CHAMBER DEVELOPMENT AND TREATMENT 
OF PSEUDOMONAS AERUGINOSA BIOFILMS WITH 
CINNAMON BARK ESSENTIAL OIL VAPOUR. 
 
5.1 Introduction 
Essential oils (EOs) are well known for their volatility and have long been 
utilised in their vapour state. The use of EO vapour as an antimicrobial has 
been well documented in the literature  (Doran et al. 2009, Fisher and Phillips 
2009, Nedorostova et al. 2009, Nostro et al. 2009, Tyagi and Malik 2010a, 
Velázquez-Nuñez et al. 2013) and several studies also include cinnamon EO 
vapour (Inouye et al. 2001, López et al. 2007, Goñi et al. 2009, Seo et al. 2015, 
Ghabraie et al. 2016, Feyaerts et al. 2018, Lee et al. 2018). Methods that are 
usually employed in these studies include the use of the disc-volatilisation 
method which often comes under many other pseudonyms. Regardless of the 
name given, this method usually involves the use of a petri-dish containing 
organisms growing on solid agar, which is then inverted and the EO is placed 
in the lid to assess antimicrobial vapour effects (Doran et al. 2009), similar to 
disc diffusion assays seen previously in this thesis (Chapter 2). The space 
between the agar surface and the lid can then be calculated and thus vapour 
can be expressed per litre of air, though this is not an accurate representation 
of concentration (Kloucek et al. 2012). Others have gone further and created 
environments for vapour testing using sealed boxes, usually plastic or glass, 
and usually a much larger volume. For example, Fisher and Phillips (2009) 
used a 600 L capacity sealed box to test a blend of citrus EOs against bacteria 
growing in broth cultures. Inouye et al  (2001) utilised 1.3 L capacity foil lined 
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plastic boxes to test bacteria growing on solid agar plates. Doran et al (2009) 
studied the effects of a combination of lemongrass and geranium EO in a 
similar manner using 64 L capacity boxes and, further to this, tested the effects 
of this EO mix on airborne microbes in office spaces by utilising an ST ProTM 
machine to disperse EO throughout a 25 m2 room. However, whilst all these 
methods are well placed in testing the potential of EO vapours as 
antimicrobials, all these studies fail to assess the EO vapour effect against 
biofilms. Studies that look at the antibiofilm properties of EO vapour are 
extremely limited. 
Nostro et al (2009) exposed biofilms grown in 35mm polystyrene plates to 
vapour of carvacrol, a common component of EOs. Laird et al. (2012) grew 
biofilms on 2 cm stainless steel discs and placed them in a 600 L capacity 
sealed box with a blend of orange and bergamot EO vapour. More recently, 
Benzaid et al (2019) treated Candida albicans biofilms, growing on collagen 
scaffolds, with peppermint (Mentha × piperita) vapour. These three studies are 
the limit to EO vapour versus biofilm work published to date, and these studies 
are limited by the use of static biofilm model systems. It is also noted that no 
study to date has investigated the effect of EO vapours against P. aeruginosa 
biofilms or of cinnamon bark EO vapour against biofilms. Therefore, the 
current chapter aimed to address the gaps within the literature and set out to 
develop a method of exposing P. aeruginosa biofilms, grown in a continuous 
flow biofilm model system, to cinnamon bark EO vapour. 
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5.1.1 Chapter progression 
The following flow diagram depicts a summary of the progression of this 
chapter. 
 
 
 
5.2 Methods 
5.2.1 Growth of P. aeruginosa biofilms in the Centre for Disease Control 
biofilm reactor (CBR) 
Standardised 48 h mature P. aeruginosa PAO1 biofilms were grown on 
polycarbonate coupons in the CBR as described in section 2.4.2.  
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5.2.2 Vapour chamber development and biofilm treatment  
A novel custom-made vapour chamber (Figure 5.1) was developed for treating 
biofilms and adapted for use with a CBR. Due to the configuration of the CBR, 
it was necessary to design a chamber that would accommodate the coupons, 
making it possible to treat them with vapour, but also minimising their 
disruption. This would most likely be achieved by avoiding the removal of the 
coupons from their rods. A feature of the CBR is easily removed rods for 
sampling, thus an airtight plastic receptacle with a shape that replicated the 
CBR could be used and adapted so as to accommodate the rods. This would 
facilitate the easy removal of rods from the CBR and replacement in this 
modified chamber, followed by subsequent treatment using vapours. It was 
anticipated that further analysis may be needed on the vapours within the 
chamber, thus a method of accessing the interior environment without 
disturbing the vapour equilibrium or the biofilms was needed. The final 
chamber design consisted of a 1.3 L volume (1300cm3) plastic container, 
measuring 11 x 27 cm, and featured a removable airtight lid. The container 
was orientated so that this lid subsequently became the base, and the top of 
the container was adapted to include four ports in which rods from the reactor 
fit snuggly, with a fifth smaller central hole in which a silicon septum was fitted. 
Vapour chambers were wrapped in foil, sterilised by autoclaving and allowed 
to dry before use. A schematic of the method for vapour treatment of mature 
biofilms is demonstrated in Figure 5.2. Briefly, coupon holder rods were 
removed from the reactor aseptically and rinsed with sterile PBS. After rinsing, 
rods were carefully inserted into the upper ports of the sterile vapour chamber. 
In circumstances where all four ports were not filled with rods containing 
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coupons, a sterile blank coupon holder was used to fill the space, to ensure a 
closed unit for vapour treatment.  
For treatment using cinnamon bark essential oil, a sterile 47 mm filter paper 
disc (Whatman, UK) was placed in a sterile 50 mm glass petri dish and placed 
in the bottom of the vapour chamber. The filter paper was then saturated with 
260 µL of cinnamon EO, representing a concentration of 0.2 µL cm-3 and the 
vapour chamber was immediately sealed. A separate negative control vapour 
chamber had a petri dish with only filter paper present. The chambers were 
incubated at 37°C for 24 hours, after which, rods were aseptically removed, 
rinsed in sterile PBS, and each coupon released into a separate tube 
containing 10 mL of TSB. Coupons were then sonicated for 10 min and 
vortexed for 30 seconds. The disaggregated biofilms were then serially diluted 
and plated onto MHA and incubated at 37°C for 24 h. During initial 
development of the vapour chamber, the position of the coupon within the 
chamber was assessed for influence on biofilm CFU. The position of coupon 
was noted, i.e. top, middle or bottom, and three coupons were enumerated for 
each position for test condition and control and the experiment was carried out 
in triplicate. Initial testing to assess coupon placement was carried out on 
biofilms grown on polycarbonate coupons and using EO concentration of 0.2 
µL cm-3.  
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Figure 5.1 – Vapour Chamber 
Diagram of 1.3 L capacity vapour chamber used for vapour treatment of biofilms 
grown in the CDC biofilm reactor. Image created by author. 
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5.2.3 Further vapour treatment  
Following confirmation that coupon position within the vapour chamber did not 
influence CFU of biofilms, further vapour treatments were carried out on 
biofilms grown on either polycarbonate (PC) or stainless steel (SS) coupons 
using similar methods to those described in section 6.2.2, with the following 
adaptions. The filter paper was placed at the bottom of the chamber and 
saturated with either 260 µL or 2.6 mL of cinnamon EO, representing 
concentrations of 0.2 µL cm-3 or 2 µL cm-3, respectively. The untreated control 
chamber contained only filter paper. The chambers were incubated at 37°C 
and biofilms grown on PC coupons were exposed for 10, 30, 60 min and 6, 12 
h and 24 hours, whilst biofilms grown on SS were exposed for 24 h only. After 
exposure to the EO vapour, rods were aseptically removed, rinsed in sterile 
PBS, and each coupon released into a separate tube containing 10 mL of TSB. 
Coupons were then sonicated for 10 min and vortexed for 30 seconds. The 
disaggregated biofilms were then serially diluted and plated onto MHA and 
incubated at 37°C for 24 h. Three coupons were enumerated for each 
condition and the experiment was carried out in triplicate.    
 
5.2.4 Assessment of tolerance 
Biofilms treated with 0.2 µL cm-3 cinnamon bark EO vapour showed complete 
reduction after 12 h of contact but then growth at 24 h time point. Following 
this observation, bacteria recovered from the 24 h time point were subcultured 
and named tolerance subculture 1 (TSC-1). Six h, 12 h and 24 h vapour 
treatment testing, as before (section 6.2.3), was carried out on TSC-1 to see 
if there was tolerance/resistance. Bacteria recovered from the 24 h time point 
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of TSC-1 testing, named tolerance subculture 2 (TSC-2), were also 
subcultured and tested in the same way. Three coupons were enumerated for 
each condition and the experiment was carried out in triplicate. 
 
5.3 Results 
5.3.1 Effect of coupon position in vapour chamber 
Results following analysis of the effect of coupon position within the vapour 
chamber are shown in Figure 5.3. There was no significant difference 
observed between coupons placed at either top, middle or bottom position in 
either treated or untreated vapour chambers (P>0.05). Because of this 
observation, data for treated or untreated coupons were collated as can be 
seen in Figure 5.4. An overall significant log reduction of 5.60 (P<0.0001) was 
observed in CFU mL-1 after 24 h exposure to EO vapour at 0.2 µL cm-3. 
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Figure 5.3 – Coupon Position Effect Assessment 
Assessment of coupon position (top, middle, or bottom) within vapour chamber 
where P. aeruginosa PAO1 biofilms grown on polycarbonate coupons are 
untreated or treated with 0.2 µL cm-3 cinnamon bark essential oil vapour for 24 h. 
 untreated biofilms;  treated biofilms. Bars show standard error; N=3; ns = not 
significant; dotted line indicating limit of detection = 10 CFU mL-1. 
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Figure 5.4 – Cinnamon Bark EO Vapour (0.2 µL cm-3) Treated P. aeruginosa 
Biofilm (24 h) 
P. aeruginosa PAO1 biofilms, grown on polycarbonate coupons, untreated or 
treated with 0.2 µL cm-3 cinnamon bark essential oil vapour for 24 h.  untreated 
biofilms;  treated biofilms. Bars show standard error; N=9; asterisks indicate 
significance; dotted line indicating limit of detection = 10 CFU mL-1. 
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5.3.2 Further vapour treatment of Pseudomonas biofilms 
Log reduction of biofilms grown on PC coupons following cinnamon bark 
vapour treatment at 0.2 µL cm-3 is shown in Figure 5.5. Log reduction after 10, 
30 and 60 min of vapour treatment was minimal (<0.5 log). Overall log 
reduction at 6 h and 12 h was 7.50 and 7.76, respectively. Following 24 h of 
vapour exposure, log reduction was 5.60, suggesting lower reduction of biofilm 
CFU mL-1 compared to that seen at 6 h and 12 h.  
Log reductions of biofilms grown on polycarbonate coupons following 
cinnamon bark vapour treatment at 2.0 µL cm-3 are shown in Figure 5.6. Log 
reductions after 10, 30 and 60 min of vapour treatment were minimal (<0.5 
log). Log reduction at 6 h, 12 h and 24 h was significantly reduced by 3.84, 
4.05 and 3.90, respectively (P<0.0001).  
Log reductions of biofilms grown on stainless steel coupons following 
exposure to cinnamon bark EO vapour are shown in Figure 5.7 and Figure 
5.8. Both concentrations produced a significant log reduction (P<0.001) in 
CFU mL-1. For 0.2 and 2 µL cm-3, cinnamon vapour produced 3.96 and 4.39 
log reductions were produced, respectively.  
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Figure 5.5 – Cinnamon Bark EO Vapour (0.2 µL cm-3) Treated P. aeruginosa 
Biofilms Grown on PC. 
P. aeruginosa PAO1 biofilms, grown on polycarbonate coupons, either untreated 
or treated with 0.2 µL cm-3 cinnamon bark essential oil vapour 10, 30 60 min and 
6, 12 and 24 h.  untreated biofilms;  treated biofilms. Bars show standard 
error; N=3; asterisks indicate significance; dotted line indicating limit of detection 
= 10 CFU mL-1. 
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Figure 5.6 – Cinnamon Bark EO Vapour (2 µL cm-3) Treated P. aeruginosa 
Biofilms Grown on PC. 
P. aeruginosa PAO1 biofilms, grown on polycarbonate coupons, either untreated 
or treated with 2 µL cm-3 cinnamon bark essential oil vapour 10, 30 60 min and 6, 
12 and 24 h.  untreated biofilms;  treated biofilms. Bars show standard error; 
N=3; asterisks indicate significance; dotted line indicating limit of detection = 10 
CFU mL-1. 
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Figure 5.7 – Cinnamon Bark EO Vapour (0.2 µL cm-3) Treated P. aeruginosa 
Biofilms Grown on SS. 
P. aeruginosa PAO1 biofilms, grown on stainless steel coupons, untreated or 
treated with 0.2 µL cm-3 cinnamon bark essential oil vapour for 24 h.  untreated 
biofilms;  treated biofilms. Bars show standard error; N=3; asterisks indicate 
significance; dotted line indicating limit of detection = 10 CFU mL-1. 
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Figure 5.8 – Cinnamon Bark EO Vapour (2 µL cm-3) Treated P. aeruginosa 
Biofilms Grown on SS. 
P. aeruginosa PAO1 biofilms, grown on stainless steel coupons, untreated or 
treated with 2.0 µL cm-3 cinnamon bark essential oil vapour for 24 h.  untreated 
biofilms;  treated biofilms. Bars show standard error; N=3; asterisks indicate 
significance; dotted line indicating limit of detection = 10 CFU mL-1. 
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5.3.3 Assessment of tolerance in Pseudomonas biofilms 
Following observation of regrowth at the 24 h contact point, the tolerance 
subculture 1 (TSC-1) was subjected to further testing, with results of this 
shown in Figure 5.9. Log reduction of TSC-1 biofilms after 6, 12 and 24 h of 
exposure were 4.89, 5.55 and 5.17, respectively (P<0.0001).  Tolerance 
subculture 2 (TSC-2) was also subjected to further testing, with results of this 
shown in Figure 5.10. Log reduction of TSC-2 biofilms after 6, 12 and 24 h of 
exposure were 5.03, 5.82 and 5.94, respectively (P<0.0001). 
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Figure 5.9 – Cinnamon Bark EO Vapour (0.2 µL cm-3) Treated TSC-1 
Biofilms Grown on PC. 
Tolerance Subculture 1 (TSC-1) biofilms, grown on polycarbonate coupons, 
either untreated or treated with 0.2 µL cm-3 cinnamon bark EO for 6, 12 and 24 h. 
 untreated biofilm;  treated biofilm. Bars show standard error; N=3; asterisks 
indicate significance; dotted line indicating limit of detection = 10 CFU mL-1. 
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Figure 5.10 – Cinnamon Bark EO Vapour (0.2 µL cm-3) Treated TSC-2 
Biofilms Grown on PC. 
Biofilms of Tolerance Subculture 2 (TSC-2) of P. aeruginosa PAO1, grown on 
polycarbonate coupons, either untreated or treated with 0.2 µL cm-3 cinnamon 
bark EO for 6, 12 and 24 h.  untreated biofilm;  treated biofilm. Bars show 
standard error; N=3; asterisks indicate significance; dotted line indicating limit of 
detection = 10 CFU mL-1. 
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5.4 Discussion 
The previous chapter investigated the effects of cinnamon bark EO in liquid 
phase and its efficacy against biofilms grown in the CDC biofilm reactor (CBR). 
This chapter aimed to investigate the anti-biofilm effects of the same EO in 
vapour phase. The first step to approach this was in the development of a 
suitable method of exposing biofilms grown using the CBR to cinnamon EO 
vapour, a biofilm model which has been advocated for biofilm growth 
previously (chapter 5). As previously discussed, other methods in the literature 
utilised sealed containers as vapour chambers to test the antimicrobial effects 
of EO vapours (Inouye et al. 2001, Doran et al. 2009, Fisher and Phillips 2009), 
thus, a unit was developed that would accommodate the coupon holder rods 
and enable treatment of biofilms growing on the coupons in situ. As this was 
a novel invention, steps were carried out to ensure that the model was robust 
and reliable in its purpose. With the understanding that as EO liquid is heated, 
the volatile components in their gaseous state will rise above the liquid in a 
general upwards direction (Clark 2009), consideration had to be given for the 
coupon placement within the chamber, as the rods are inserted vertically with 
an evident hierarchy in coupon position in relation to the source of EO vapour. 
Thus, initial experiments aimed to address concerns regarding this by treating 
coupon position as an independent variable and analysing results to assess 
any significant differences in CFU mL-1. Findings from this study indicated that 
in both untreated and treated samples, log reduction in CFU mL-1 was not 
significantly different, regardless of whether the coupon was at the top, middle 
or bottom and thus, a conclusion can be drawn that coupon position is no 
longer a factor that needs considering in this model. Other general notes 
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regarding the design of the vapour chamber may consider the possibility for 
“leaks”. Whilst a concerted effort was made to ensure the rods were fitted 
snuggly, and the lid/base had intact seals, this was not an issue that was 
focussed on. In fact, this research welcomed the occurrence of minor escaping 
of vapour as this would represent that of real-life scenarios where this method 
of application may be used.  
In the previous chapter of this study, evidence showed that a concentration of 
0.2% (v/v) cinnamon bark EO in broth dilution was capable of producing >3 
log reductions in biofilms grown on polycarbonate coupons, after 24 h contact, 
and at a concentration of 2% (v/v), greater than 8 log reductions within 10 
minutes of contact time were observed. Whilst it is difficult to make a direct 
comparison of broth dilution concentrations to cinnamon bark EO in vapour 
form, volumes of EO used in the base of the vapour chamber were chosen to 
represent practical volumes, which kept cost in mind, though also reflected 
comparable concentrations.  
Results from the coupon position experiment were collated to represent 24 
hour testing of biofilms with 0.2 µL cm-3 EO vapour. This revealed a significant 
5.60 log reduction of biofilms after this contact time (P<0.0001). Further testing 
to include lower contact times led to findings showing minimal log reduction 
after 10, 30 and 60 min, but a 7.50 and 7.76 log reduction after 6 h and 12 h, 
respectively, the latter representing a 100% reduction in CFU mL-1. These 
results, in combination with the results from 24 h, indicate an increase in 
observed biofilm growth after 12 h exposure and the possibility that P. 
aeruginosa showed tolerance to the EO vapour. To investigate this further, 
colonies from the 24 h contact point of this experiment were subcultured, used 
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to inoculate the CBR and grow mature biofilms, and re-tested in the vapour 
chamber for 6 to 24 h using the same concentration of EO vapour. This strain 
was called tolerance subculture 1 (TSC-1) and results showed that TSC-1 
were less susceptible to the vapour than their original counterpart. Whilst the 
original biofilms were reduced to less than 1.5 log CFU mL-1 after 6 h, TSC-1 
did not reduce to less than 3 log CFU mL-1 throughout the testing. This was 
also mirrored in further testing carried out on a subculture of TSC-1 (i.e. TSC-
2). Thus, this indicates that reduction by the vapour was still moderately 
successful, in that it achieved a >4 log reduction, the effect was markedly 
different from the original testing and further supports the hypothesis that P. 
aeruginosa biofilms exhibited tolerance to cinnamon bark EO.  This is 
supported by studies that have reported P. aeruginosa to show intrinsic 
tolerance to both EOs as a whole and EO components. Cox and Markham 
(2007) found that P. aeruginosa exhibited intrinsic tolerance to eugenol, 
linalool, geraniol, a-terpineol and citral, and may have an energy dependent 
multidrug resistance efflux pump system. MexAB-OprM is an efflux system 
driven by ATP that is reported to be involved in P. aeruginosa tolerance to 
hydrophobic solvents such as hexane and p-xylene (Li, Zhang, et al. 1998). 
These reports could explain the tolerance that is being observed in results of 
this study, though further research is required to corroborate this. In contrast, 
Becerril et al (2012) found that cinnamon oil did not cause an increase in MIC 
in any of the 48 isolates they studied, nor did it induce any tolerance in P. 
aeruginosa following 50 passages of EO treatment. Despite these findings, it 
is evident that cinnamon bark EO vapour is capable of reducing the viability of 
preformed mature biofilms at low concentrations. Although current published 
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literature surrounding the effects of EO vapour on biofilms is limited, similar 
findings have been seen for cinnamon EO direct contact treatment of biofilms 
(chapter 5) and in work investigating cinnamon EO vapour against planktonic 
bacteria. For example, Utchariyakiat et al. (2016) found cinnamon bark vapour 
to be effective against P. aeruginosa at a 0.5mg/L of air concentration, which 
is a very low concentration. Inouye et al  (2001) found that cinnamon bark EO 
vapour had a minimum inhibitory dose range of 1.56 – 12.5 mg/L air against a 
range of Gram-negative and Gram-positive bacteria. Křůmal et al. (2015) 
conducted a study investigating the antimicrobial activity of EOs placed inside 
a desiccator with planktonic bacteria and found that 5 mL of cinnamon EO (leaf 
and bark mix) reduced bacterial numbers by 5 log in 3 days. These findings, 
and the findings presented in this chapter, are in contrast to research carried 
out by Goñi et al (2009) and López et al (2007) who found that cinnamon EO 
vapour was not effective against P. aeruginosa, however, neither of these 
studies indicate if the EO was leaf or bark origin and discussions in chapter 4 
have already outlined the importance of this detail, highlighting the inferior 
antimicrobial activity of leaf oil compared to bark oil.  
Interestingly, in the present study, when volume of oil used in the chamber 
was increased, the treated biofilms were less susceptible to the vapour 
compared to those treated with a lower concentration of EO vapour. The log 
reductions seen for biofilms exposed to 0.2 µL cm-3 EO vapour was 
significantly lower (P<0.01) than that of log reductions of biofilms exposed to 
2 µL cm-3 vapour. This dose effect is especially obvious at 6 hour and 12 hour 
time points where biofilms treated with 0.2 µL cm-3 were more reduced, if not 
eradicated completely, compared to biofilms treated with 2 µL cm-3 vapour 
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which showed growth throughout testing. Without further investigations it is 
difficult to speculate as to why this may be occurring, though comment can be 
made on the volatility of components within the oil. Up to 300 volatile 
compounds have been reported to be found in essential oil from the cinnamon 
plant (Kazemi and Mokhtariniya 2016) and these components can be found in 
trace amounts or comprise up to 90% amount of the EO (Senatore 2002, 
Nabavi et al. 2015). In liquid phase, the proportions of these components are 
found to be fairly stable (Reyes-Jurado et al. 2019). However, because each 
compound has a different vapour pressure and thus a varying volatility, the 
volatile compounds will disperse at different rates until an equilibrium is 
reached in a closed environment (Kloucek et al. 2012). Cinnamaldehyde is 
known to be the main constituent of cinnamon bark EO and is reported to be 
responsible for the antimicrobial activity of this oil (Nabavi et al. 2015) and 
within the oil presented in this study, represents 85% (chapter 4). More 
investigations are required to assess the composition of the vapour chamber 
headspace at these different vapour concentrations, which would potentially 
shed light on the arrangement of volatile compounds in this space and give a 
possible explanation for the differences seen in efficacy.  
Concentrations of vapour used in this chapter were loosely based on the 
concentrations of liquid cinnamon bark EO used to treat biofilms in the 
previous chapter. In the previous chapter, concentrations 0.02, 0.2 and 2% 
(v/v) were used and thus, by using a crude conversion of v/v to µL per L of air 
to represent a vapour concentration in percentage, the same concentrations 
were used here, with the exception of the higher concentration as this would 
have been an inappropriate volume of oil at the bottom of the chamber. 
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However, to ensure accurate depiction of the concentration of oil in vapour 
treatment, concentrations were reported as µL cm-3. The previous chapter 
(Chapter 5) identified differences when treating biofilms grown on PC coupons 
compared to those grown on SS coupons. Although the results of the 0.2 µL 
cm-3 vapour treatment of biofilms agreed to the previous findings, as 
reductions were greater for PC biofilms than SS biofilms, the same was not 
observed in the 2 µL cm-3 vapour treated biofilms. This observation may also 
be in connection with the possible differences in vapour phase antimicrobials 
at the different concentrations.  
Another notable outcome of this research is that, if a conversion of the vapour 
concentration is carried out to translate 2 µL cm-3 to µL per L of air and thus 
percentage EO vapour, 0.2 µL cm-3 would be expressed as 0.02% (v/v). This 
concentration is up to 100-fold less than concentrations used in the direct 
treatment experiments of chapter 5, though was capable of achieving 
comparable log reductions in preformed biofilms compared to higher 
concentrations used in liquid application. A similar phenomenon was seen in 
work by Tyagi and Malik  (2010b) who reported in their studies assessing 
activity of lemongrass EO against Candida albicans that lemongrass EO was 
much more potent in vapour form compared to lemongrass EO in broth 
dilutions. 
The US Environmental Protection Agency (EPA) defines a disinfectant as a 
successful antibiofilm agent when it is capable of producing a 6 log reduction 
of biofilm after no more than 10 min of exposure (Environmental Protection 
Agency 2017). Whilst the findings presented in this chapter do not advocate 
the replacement of current disinfection methods with cinnamon vapour, its use 
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may however provide additional steps in decontaminating areas prone to 
biofilm formation and supporting existing protocols. Current vapour 
decontamination protocols include hydrogen peroxide vapour/aerosolisation 
systems and gaseous ozone treatments (Boyce 2016). Work investigating the 
decontamination of various bacteria from surfaces using gaseous ozone 
showed a maximum log reduction of 5.05, and this study does not imply that 
bacteria were in biofilm state (Moat et al. 2009). Hems et al. (2005) found that 
gaseous ozone had no significant effect on Enterococcus faecalis biofilms and 
Marino (2018) advocates the use of gaseous ozone for longer periods of time, 
i.e. overnight, to achieve adequate reduction of biofilms in small spaces. 
Watson et al. (2018) found that hydrogen peroxide vapour (HPV) was able to 
completely inactivate biofilms, including P. aeruginosa biofilms, after 100 min 
of exposure, and Otter et al (2010) reported that no Gram-negative rod 
bacteria were cultivated from 63 sites within an intensive care unit following 
HPV decontamination, although this was following a 12 hour decontamination 
process and an overnight aeration step. The results from this chapter suggest 
that cinnamon bark EO vapour shows promise in the context of air and surface 
decontamination, especially in healthcare settings where current protocols use 
dangerous substances (Laird et al. 2012) and often require extensive 
decontamination times.  
In summary, this chapter aimed to address the gaps in literature which have 
so far failed to investigate the effect of cinnamon bark EO vapour against P. 
aeruginosa biofilms, grown in non-static biofilm growth models. This chapter 
presents the development of a novel vapour chamber designed to assess the 
vapour effects of EOs and similar compounds on biofilm viability. The CBR is 
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an established model for investigating biofilm growth in vitro, therefore this 
chamber was adapted to be used in conjunction with the CBR to assess the 
effects of vapour exposure to biofilms grown using it. Initial experiments using 
this vapour chamber assessed the setup and whether its design affected the 
application of EO vapour to the biofilms. It was found that the position of the 
coupon did not influence the effect of the EO vapour and thus the vapour 
chamber was suitable for further testing of vapour against biofilms. Cinnamon 
vapour at 0.2 µL cm-3 produced a complete reduction of biofilm after 12 h of 
contact, though 24 h contact was not as effective. This occurrence was further 
investigated to explore the possibility for tolerance of P. aeruginosa to 
cinnamon vapour. After passages of treatment, although the bacteria were not 
as susceptible to the cinnamon vapour, they were still significantly reduced by 
>4 log CFU mL-1. Interestingly, when the volume of oil in the vapour chamber 
was increased, there was no improvement in antibiofilm effects and efficacy 
was in fact reduced. Speculation may suggest that there may be differences 
in the equilibrium of volatile components within the chamber, but further 
investigations are required. Overall, cinnamon EO vapour shows promise in 
contributing to current cleaning processes and may aid in decontamination 
that utilises no touch protocols. 
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6 SELECTED ION FLOW TUBE MASS SPECTROMETRY 
(SIFT-MS) ANALYSIS OF CINNAMON EO VAPOUR AND 
EFFECTS OF CINNAMON EO COMPONENTS ALONE AND 
IN COMBINATION 
 
6.1 Introduction 
In the previous chapter (chapter 6), evaluation of the antimicrobial effects of 
cinnamon bark EO in vapour phase revealed that biofilms were less 
susceptible when EO vapour concentration was increased from 0.2 µL cm-3 to 
2 µL cm-3. It was hypothesised that the proportion of volatile components within 
the vapour chamber, at the different concentrations, were causing changes in 
anti-biofilm efficacy. The complexity of EOs, and their volatility, has already 
been discussed (chapter 3-6). Constituents of EOs can typically be classified 
into one of many compound classifications; alcohols, ethers, aldehydes, 
ketones, esters, amines, amides, phenols, heterocycles, and terpenes (Dhifi 
et al. 2016). Each of these constituents have a different vapour pressure, 
which can be used to indicate the rate of evaporation of a liquid, with 
substances that have higher vapour pressures, vaporising more readily 
(Speight 2019). The composition of a vapour mixture produced from an EO 
will be dependent on the vapour pressure of each constituent in the liquid 
phase (Guenther 1948).  
The composition of cinnamon bark EO in liquid phase was analysed using gas 
chromatography mass spectrometry (GC-MS) in chapter 3 which identified 6 
main compounds including cinnamaldehyde, limonene, eucalyptol, eugenol, 
benzyl benzoate and linalool. Analysis of the gaseous headspace that 
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cinnamon EO generates can be used to quantify these identified compounds. 
Selected ion flow tube mass spectrometry (SIFT-MS) is an analysis technique 
that has already been utilised in this thesis (chapter 3), and is a form of direct 
mass spectrometry that utilises soft chemical ionization to produce real-time 
quantitative analysis of volatile compounds (Smith and Španěl 2011). Other 
methods that have been used to accomplish essential oil volatile analysis 
include solid-phase microextraction (SPME) with follow up analysis using gas 
chromatography mass spectrometry (GC-MS), gas chromatography with 
flame ionisation detection (GC-FID) and wet effluent diffusion denuder 
(WEDD) techniques with GC-MS analysis (Tyagi and Malik 2011, Křůmal et 
al. 2015, Stojanović et al. 2019). However, all of these techniques necessitate 
extraction of the volatiles from the methods in which they are generated, often 
requiring pre-concentration of compounds before analysis and/or 
consideration for the fibre or compound absorption material. To my knowledge, 
there are no other studies that utilise SIFT-MS to investigate the vapour phase 
of essential oils or investigate vapour composition to elucidate anti-biofilm 
effects in situ. Therefore, this chapter aims to use SIFT-MS to analyse the 
headspace of vapour chambers used to treat biofilms and to investigate the 
composition of the volatile mixture produced from vaporisation of cinnamon 
bark EO within these chambers. This will potentially explain the differences 
seen in antimicrobial activity of cinnamon bark EO vapour at varying 
concentrations.  
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6.1.1 Chapter progression 
The following flow diagram depicts a summary of the progression of this 
chapter. 
 
 
 
6.2 Methods 
6.2.1 Vapour chamber headspace analysis 
The vapour chamber setup was similar to the method described in chapter 6. 
Two vapour chambers were set up as previously described; one chamber 
contained a lower concentration (LC) of cinnamon bark EO vapour (0.2 µL cm-
3) and the second chamber contained a higher concentration (HC; 2 µL cm-3). 
Sterile blank rods were used in place of rods holding active biofilms and 
chambers were incubated at 37°C for the duration of the experiment, with the 
exception of removal from incubation during sampling. Samples were taken at 
10, 30 and 60 min, and 6, 12 and 24 h. Rods were not removed at these time 
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points as sampling using the SIFT-MS instrument mimicked the removal of 
rods at these times. SIFT-MS was used to analyse the headspace of vapour 
chambers using methods adapted from Slade et al. (2017). Briefly, chambers 
were set up as previously described in chapter 6, and the headspace of the 
chamber was analysed using SIFT-MS (Instrument Science Limited, UK) in 
‘Selected Ion’ mode to quantify headspace concentration of cinnamaldehyde, 
limonene, benzyl benzoate, eucalyptol, eugenol and linalool. Three precursor 
ions of H3O+, NO+ and O2+ were used. The silicon septum of the vapour 
chamber was wiped with 70% ethanol before being pierced with a sterile 
needle attached to the SIFT-MS direct sampling inlet. The sample was vented 
using another sterile needle attached to a 0.2 µm syringe filter (Sartorious 
Stedim Biotech, Germany) which allowed headspace gases to flow freely. The 
SIFT-MS instrument was run for 5 seconds to allow for settling of gases and 
then an average part per billion (ppb) of analytes was calculated over 10 
seconds of readings. The experiment was carried out independently in 
triplicate and results are express as average ppb. 
 
6.2.2 Minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of cinnamon bark essential oil components  
Results from SIFT-MS analysis of the vapour chambers (section 7.2.1) 
identified eucalyptol as a dominant compound present in the headspace of 
both low concentration (LC) and high concentration (HC) chambers. 
Therefore, eucalyptol was chosen, and its antimicrobial efficacy was 
compared to that of cinnamaldehyde, the dominant constituent of the 
condensate. The MIC and MBC was determined for eucalyptol and 
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cinnamaldehyde liquid components, alone and in combination, using methods 
described in chapter 4. Combinations of eucalyptol and cinnamaldehyde were 
mixed to reflect the ratios of the components at different time points within the 
vapour chamber headspace, based on methods and results of section 7.2.1. 
The ratios of cinnamaldehyde to eucalyptol used in combinations 1-6 are 
shown in Table 6.1. These ratios were calculated by dividing the concentration 
of eucalyptol present in the headspace by the concentration of 
cinnamaldehyde present in the headspace. Pure chemical compounds of 
eucalyptol (Sigma Aldrich, Dorset, UK) and cinnamaldehyde (Sigma Aldrich, 
Dorset, UK) were mixed reflecting the ratios described and diluted serially. The 
final concentration of cinnamaldehyde in combinations 1-3 ranged from 
0.007% - 4% (v/v), with corresponding eucalyptol concentration ranging from 
0.01% - 16.4% (v/v). Final tested concentrations of cinnamaldehyde in 
combinations 4-6 ranged from 0.007% - 2% (v/v), with corresponding 
eucalyptol concentration ranging from 0.07% - 28.75% (v/v).  
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6.2.3 Data analysis  
Two-way ANOVA with Tukey’s multiple comparison was used to assess 
significant differences between component concentrations in vapour 
chambers.  
 
6.3 Results 
6.3.1 SIFT-MS analysis of vapour chamber headspace 
Results of SIFT-MS analysis of headspace from the vapour chamber 
containing lower concentration (LC) of cinnamon bark EO (0.2 µL cm-3), the 
concentration that was most effective when looking at results from the previous 
chapter, is demonstrated in Figure 6.1 and Table 6.2. Sampling from the LC 
chamber between 10 min and 12 h revealed that eucalyptol was the dominant 
compound during this timeframe. Eucalyptol was significantly higher than all 
other compounds measured over the first 12 h of sampling (P<0.0001) and 
Table 6.1 – EO Liquid Component Combinations 
Ratios of cinnamaldehyde to eucalyptol used to produce combinations for 
minimum inhibitory concentration and minimum bactericidal concentration testing. 
Combination Cinnamaldehyde:eucalyptol ratio 
1 1:3.55 
2 1:1.95 
3 1:0.87 
4 1:12.71 
5 1:11.29 
6 1:7.3 
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represented 67% of the total measured compounds after 10 min of incubation 
in the LC chamber. However, after an initial significant increase in 
concentration (P<0.0001), eucalyptol concentration significantly decreased 
after 60 min (P<0.0001). In contrast to this, in the same LC chamber, 
cinnamaldehyde concentration increases over time and its concentration after 
24 h of incubation is significantly greater than its concentration at 10 min 
(P<0.0001). At the 24 h sampling point, cinnamaldehyde is the dominant 
compound.  Eugenol, linalool and benzyl benzoate concentrations did not 
significantly change over time (P>0.005) and limonene concentration 
significantly decreased over time (P<0.0001) in the LC chamber. 
 
 144 
 
 
F
ig
u
re
 6
.1
 –
 A
n
a
ly
s
is
 o
f 
C
in
n
a
m
o
n
 B
a
rk
 E
O
 V
a
p
o
u
r 
(0
.2
 µ
L
 c
m
-3
).
 
C
o
n
c
e
n
tr
a
ti
o
n
s
 (
p
p
b
) 
o
f 
c
o
m
p
o
u
n
d
s
 p
re
s
e
n
t 
in
 h
e
a
d
s
p
a
c
e
 o
f 
v
a
p
o
u
r 
c
h
a
m
b
e
r 
c
o
n
ta
in
in
g
 0
.2
 µ
L
 c
m
-3
 c
in
n
a
m
o
n
 b
a
rk
 E
O
 o
v
e
r 
ti
m
e
. 
 1
0
 
m
in
; 
 3
0
 m
in
; 
 6
0
 m
in
; 
 6
 h
; 
 1
2
 h
; 
 2
4
 h
. 
N
=
3
; 
b
a
rs
 s
h
o
w
 s
ta
n
d
a
rd
 e
rr
o
r.
 
 145 
T
a
b
le
 6
.2
 –
 P
e
rc
e
n
ta
g
e
 A
n
a
ly
s
is
 o
f 
C
in
n
a
m
o
n
 B
a
rk
 E
O
 V
a
p
o
u
r 
(0
.2
 µ
L
 c
m
-3
) 
C
o
n
c
e
n
tr
a
ti
o
n
 o
f 
c
o
m
p
o
u
n
d
s
 p
re
s
e
n
t 
in
 h
e
a
d
s
p
a
c
e
 o
f 
v
a
p
o
u
r 
c
h
a
m
b
e
r 
c
o
n
ta
in
in
g
 0
.2
 µ
L
 c
m
-3
 c
in
n
a
m
o
n
 b
a
rk
 E
O
. 
V
a
lu
e
s
 a
re
 e
x
p
re
s
s
e
d
 a
s
 
p
e
rc
e
n
ta
g
e
 o
f 
to
ta
l 
a
n
a
ly
te
s
 m
e
a
s
u
re
d
 b
y
 S
IF
T
-M
S
 ±
 s
ta
n
d
a
rd
 e
rr
o
r;
 N
=
3
. 
T
im
e
 o
f 
s
a
m
p
li
n
g
 
C
o
n
c
e
n
tr
a
ti
o
n
 (
%
) 
E
u
g
e
n
o
l 
L
in
a
lo
o
l 
E
u
c
a
ly
p
to
l 
C
in
n
a
m
a
ld
e
h
y
d
e
 
B
e
n
z
y
l 
b
e
n
z
o
a
te
 
L
im
o
n
e
n
e
 
1
0
 m
in
 
0
.0
8
±
0
.0
2
 
6
.3
2
±
0
.0
3
 
6
6
.7
5
±
1
.8
6
 
5
.2
8
±
0
.9
6
 
0
.0
1
±
0
 
2
1
.5
5
±
0
.9
1
 
3
0
 m
in
 
0
.1
4
±
0
.0
1
 
7
.2
3
±
0
.0
8
 
6
6
.3
7
±
1
.6
3
 
6
.0
9
±
0
.6
7
 
0
.0
2
±
0
 
2
0
.1
6
±
0
.9
0
 
6
0
 m
in
 
0
.1
4
±
0
.0
3
 
7
.8
5
±
0
.1
4
 
6
4
.6
5
±
1
.0
9
 
7
.9
6
±
0
.4
5
 
0
.0
2
±
0
 
1
9
.3
8
±
0
.7
9
 
6
 h
 
0
.3
0
±
0
.0
8
 
1
0
.6
2
±
0
.5
3
 
5
3
.7
6
±
0
.7
0
 
1
5
.1
5
±
0
.9
7
 
0
.0
3
±
0
 
2
0
.1
4
±
0
.2
2
 
1
2
 h
 
0
.5
0
±
0
.0
9
 
1
2
.8
8
±
0
.7
3
 
4
1
.7
3
±
2
.0
0
 
2
1
.4
4
±
2
.5
7
 
0
.0
3
±
0
 
2
3
.4
1
±
1
.3
7
 
2
4
 h
 
0
.6
5
±
0
.1
7
 
1
5
.7
8
±
0
.8
0
 
2
7
.3
6
±
1
.2
4
 
3
1
.5
9
±
0
.3
8
 
0
.0
3
±
0
 
2
4
.5
9
±
0
.1
9
 
A
v
e
ra
g
e
 
0
.3
0
±
0
.0
9
 
1
0
.1
1
±
1
.5
 
5
3
.4
4
±
6
.5
5
 
1
4
.5
9
±
4
.2
4
 
0
.0
2
±
0
 
2
1
.5
4
±
0
.8
4
 
 
 146 
Results of SIFT-MS analysis of headspace from vapour chamber containing 
higher concentration (HC) of cinnamon bark EO (2 µL cm-3), the concentration 
that was least effective when looking at results from the previous chapter, is 
demonstrated in Figure 6.2 and Table 6.3. Sampling from this chamber reveals 
that eucalyptol remained the dominant compound over the entire 24 h 
sampling period. Although eucalyptol demonstrated a significant increase 
between 10 min and 60 min (P<0.0001), and then a significant decrease 
between 60 min and 24 h (P<0.0001), the initial concentration of eucalyptol at 
10 min and the final concentration at 24 h were not significantly different 
(P>0.005) in the HC chamber. In the HC chamber each concentration of 
cinnamaldehyde measured was not significantly different from the previous 
time point (P>0.05), however the final concentration at 24 h was significantly 
higher than the initial concentrations at 10 min (P<0.01). Eugenol, linalool and 
benzyl benzoate concentrations did not significantly change over time 
(P>0.005) and although limonene concentration fluctuated, its concentration 
did not significantly change after 24 h (P>0.05).  
A comparison of the average content of components (%) in both liquid phase 
and vapour phase is demonstrated in Table 6.4. In liquid phase, 
cinnamaldehyde represented 85.31% of total composition, though in vapour 
phase when cinnamon bark EO was at 0.2 µL cm-3 and 2 µL cm-3, 
cinnamaldehyde represented 0.3 and 0.12%, respectively. In liquid phase, 
eucalyptol represented 3.82% of total composition, though in vapour phase 
when cinnamon bark EO was at 0.2 µL cm-3 and 2 µL cm-3, eucalyptol 
represented 53.44 and 68.27%, respectively.  
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6.3.2 MIC and MBC of liquid components 
The MIC and MBC for cinnamon bark EO components alone or in combination 
against P. aeruginosa PAO1 are demonstrated in Table 6.5. Cinnamon bark 
EO MIC/MBC against this bacterium was previously determined (chapter 4) 
and these values were included in Table 6.5 for reference. Eucalyptol 
possessed no antimicrobial activity at concentrations ≤30% (v/v). The MIC of 
cinnamaldehyde alone was 0.06% (v/v) which is lower than the MIC of the 
whole EO, although MBC was 0.12% (v/v) which is unchanged from cinnamon 
EO. Combinations 1, 5 and 6 all had MIC and MBC values comparable to that 
of cinnamon EO. Combinations 2 and 3 both had improved MIC values 
Table 6.4 – Cinnamon Bark EO Composition of Constituents 
Composition comparison of components in cinnamon bark EO liquid phase, and 
vapour phase at different concentrations. N=3 
Component 
Percentage (%) of cinnamon bark EO 
composition 
Liquid 
phase a 
Vapour 
phase (0.2 
µL cm-3) b 
Vapour 
phase (2 µL 
cm-3) c 
Cinnamaldehyde 85.31 0.30 0.12 
Limonene 4.67 10.11 6.54 
Eucalyptol 3.82 53.44 68.27 
Eugenol 3.37 14.59 5.21 
Benzyl benzoate 1.94 0.02 0.02 
Linalool 0.90 21.54 19.84 
a results obtained in chapter 4 
b & c average percentage of components measured from sampling points over 24 h  
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compared to cinnamon EO and similar to that of cinnamaldehyde alone, 
although MBC values were unchanged. Combination 4 had an increased MIC 
and MBC value of 0.25% (v/v) compared to cinnamon bark EO.   
 
 
 
Table 6.5 – Inhibitory and Bactericidal Effects of Cinnamon Bark EO and its 
Components 
The minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of cinnamon bark EO, and individual compounds either alone 
or in combination, against P. aeruginosa PAO1. N=4 
Tested 
EO/compound/combination 
Concentration (% v/v) 
MIC MBC 
Cinnamon bark EOa 0.12 0.12 
Cinnamaldehyde 0.06 0.12 
Eucalyptol >30 >30 
Combination 1b 0.12 0.12 
Combination 2c 0.12 0.12 
Combination 3d 0.06 0.12 
Combination 4e 0.25 0.25 
Combination 5f 0.12 0.12 
Combination 6g 0.12 0.12 
a MIC and MBC results from chapter 4 
b 1:3.55 c 1:1.95 d 1:0.87 e 1:12.71 f 1:11.29 g 1:1.73; cinnamaldehyde:eucalyptol ratio used. 
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6.4 Discussion 
The previous chapter (chapter 6) investigated the anti-biofilm effects of 
cinnamon bark EO vapour and results demonstrated decreased success when 
concentration of EO was increased within the chamber. This chapter continued 
to investigate these findings and did so by focusing on analysing the 
headspace of vapour chambers containing cinnamon bark EO at different 
concentrations, with the aim to elucidate why this outcome occurred. The 
vapour chambers were designed with a silicon port to facilitate in situ sampling 
of the headspace. Analysis was carried out using SIFT-MS, an instrument 
capable of identifying and quantifying volatile organic compounds (VOCs) and 
a method that has been described extensively elsewhere (Wang et al. 2002, 
Španěl et al. 2006, Smith and Španěl 2011, Lacko et al. 2019). Other methods 
such as SPME, GC-FIDD and WEDD can be time-consuming and cannot be 
used to easily measure constant chemical evolution of a headspace (Lacko et 
al. 2019). The advantage of using SIFT-MS is that this method does not suffer 
from these drawbacks, there is no need for pre-concentration or extraction of 
volatiles and thus, real-time in situ sampling is carried out without disruption of 
the vapour environment and experiment. After literature survey, it is to the best 
of my knowledge that this study is the first to use SIFT-MS to analyse EO 
headspace and quantify the composition of the vapour mixture produced. 
Whilst studies have been carried out to evaluate the vapour composition of 
EOs (Tyagi and Malik 2011, Křůmal et al. 2015, Stojanović et al. 2019), these 
studies use the methods described above, they do not assess alternative 
concentrations of EOs and sampling is not in the circumstance of anti-biofilm 
testing. Analysis of cinnamon bark EO using GC-MS in chapter 4 identified the 
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main components in liquid phase. These components were used in the 
experimental setup of SIFT-MS to identify their composition in the vapour 
headspace. In the lower concentration (LC) vapour chamber, containing 260 
µL of cinnamon EO, SIFT-MS analysis revealed that after 10 minutes of 
incubation, eucalyptol was the dominant constituent. This is in contrast to the 
liquid phase composition of cinnamon EO which identified cinnamaldehyde as 
the dominant constituent. This observation was mirrored in the higher 
concentration (HC) vapour chamber containing 2.6 mL of EO, where 
eucalyptol was also dominant in the headspace. An EO vapour mixture is the 
result of volatile components of the EO going into gaseous state. Its 
composition relies on the partial vapour pressures of the EO constituents. In 
circumstances where a liquid is comprised of constituents possessing varying 
vapour pressures, components with the higher vapour pressure, and thus 
greater volatility, will be found in higher concentrations within the headspace 
(Guenther 1948). The vapour pressure of the constituents of cinnamon bark 
EO are demonstrated in Table 6.6. This data shows that of the 6 compounds 
present in cinnamon EO, eucalyptol has the highest vapour pressure which 
explains the dominance of eucalyptol in the vapour phase of cinnamon EO. 
This is comparable to results demonstrated by Křůmal et al. (2015) who also 
compared the composition of cinnamon oil (bark/leaf mix) in both liquid and 
gaseous states using WEDD, and found that although cinnamaldehyde was 
the major constituent of the liquid phase, it was no longer the main compound 
in vapour state. Stojanović et al (2019) found that in several species of Thymus 
(thyme) essential oils, the main constituent in liquid phase was not the main 
constituent in gaseous state and Tyagi and Malik (2011) also observed 
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differences in composition when comparing liquid and vapour state of 
eucalyptus EO, although the balance of constituents remained similar.  
 
Findings presented in this study, in addition to those from the literature, 
highlight the importance of determining composition of both the liquid phase 
and vapour phase of EOs, and that for cinnamon bark EO, knowledge of the 
composition of the EO in liquid phase cannot be translated to composition of 
the same EO in vapour phase. This is supported by Leggio et al. (2017) who 
advocate the critical nature of determining the composition of EOs in gaseous 
phase in order to fully understand its activity. 
Eucalyptol was the dominant component in both LC and HC vapour chambers, 
however, whilst eucalyptol stayed >64% of total components during the entire 
24 h sampling period in the HC chamber, in the LC vapour chamber there was 
Table 6.6 – Vapour pressures of constituents of cinnamon bark EO (mm Hg) 
Constituent 
Vapour pressure 
(at 25±1.5 °C) 
Reference 
Cinnamaldehyde 0.0289 mm Hg (Perry et al. 1997) 
Limonene 1.51 mm Hg 
(Li, Perdue, et al. 
1998, Hoskovec et 
al. 2005) 
Eucalyptol 1.90 mm Hg 
(Riddick et al. 
1986) 
Eugenol 0.0221 mm Hg 
(Van Roon et al. 
2005) 
Benzyl benzoate 0.000224 mm Hg 
(Daubert and 
Danner 2013) 
Linalool 0.159 mm Hg 
(Li, Perdue, et al. 
1998) 
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reduction in eucalyptol and this component was no longer dominant after 24 
h. The main constituent after 24 h in the LC chamber was cinnamaldehyde. 
This is a possible explanation for the greater antimicrobial efficacy of the LC 
chamber against biofilms described in chapter 6 as cinnamaldehyde is 
suggested to be the main antimicrobial constituent. In the HC chamber, 
cinnamaldehyde did not exceed 8.78% of the total composition which could 
also explain the inferior anti-biofilm effects of the HC chamber. Studies have 
reported that minor components of oil composition are often critical in the 
antimicrobial effects of the whole oil (Burt 2004), and although the effects of 
the minor components are often reported as synergistic (Goñi et al. 2009), 
there have been reports of antagonism (Gill et al. 2002, Mourey and Canillac 
2002, Bassolé and Juliani 2012). Synergism is when combinations of 
antimicrobials result in an increase in antimicrobial activity that is greater than 
the sum of individual components, whereas antagonism is a decrease in 
antimicrobial activity when in combination (Chouhan et al. 2017). Thus, this 
chapter continued investigations to evaluate the antimicrobial properties of 
eucalyptol and cinnamaldehyde, alone and in combination, to look for 
synergistic or antagonistic behaviour in liquid phase when used to treat P. 
aeruginosa. Cinnamaldehyde alone had an MIC lower than that of the whole 
oil (Table 6.5), whereas eucalyptol possessed no antimicrobial activity at 
tested concentrations. Combinations of these two constituents revealed that 
when eucalyptol was less than cinnamaldehyde in the final mixture (i.e. 
combination 3), the MIC and MBC reflected the MIC and MBC values of 
cinnamaldehyde alone. This finding is supported by Tak and Isman (2017) 
who found that when eucalyptol was added to cinnamaldehyde at a ratio of 
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1:0.8 (cinnamaldehyde:eucalyptol), synergistic effects were observed and 
insecticidal activity was increased. In the present study, when the combination 
resulted in eucalyptol being no more than 12 times greater than 
cinnamaldehyde (i.e. combinations 1, 2, 5 and 6), the MIC and MBC values 
were comparable to the MIC/MBC value for the whole EO, and when 
eucalyptol was more than 12 times that of cinnamaldehyde in the mixture (i.e. 
combination 4), the MIC and MBC value was increased. This not only supports 
the literature which suggests that cinnamaldehyde exerts the majority of 
cinnamon bark EOs’ antimicrobial effects, but these findings also indicate that 
eucalyptol may have an additive or antagonistic effect against 
cinnamaldehyde, both in liquid phase and possibly in vapour phase, 
depending on the ratio of the two components. Of course, it is also noted that 
throughout the sampling of vapour chambers at both concentrations, limonene 
is >18% of the composition at all sampling points. Limonene is reported to 
possess antimicrobial activity (van Vuuren and Viljoen 2007). Tak and Isman 
(2017) demonstrated that the addition of limonene to cinnamaldehyde at a 
ratio of 0.8 (w:w) caused synergistic activity, whilst Andrade-Ochoa et al. 
(2018) found that limonene in equal parts with cinnamaldehyde produced 
synergistic activity. However, to my knowledge no data is available to describe 
the synergistic or antagonistic effects of combining limonene with 
cinnamaldehyde at higher ratios. Therefore, when considering findings 
presented in this chapter, it is difficult to attribute the antagonistic effects 
observed in the data presented here to eucalyptol alone, when other minor 
components may be contributing. Synergy can also be evaluated using other 
methods including the checkerboard assay and fractional inhibitory 
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concentration (FIC) index, the E-test method or an immunometric 
checkerboard assay with fluorescent output for real-time synergy analysis 
(Langeveld et al. 2014).  
In summary, despite cinnamaldehyde being reported previously in this thesis 
(chapter 4) as the dominant compound within cinnamon bark EO liquid, the 
findings from this chapter demonstrate that this is not reflected in the 
composition of cinnamon bark EO in vapour phase. This study highlights the 
importance of vapour composition analysis when the intended use of an EO is 
in its vapour form, as composition of the liquid phase does not always reflect 
the composition of the vapour. Eucalyptol is known to have the highest vapour 
pressure of the components identified in cinnamon bark EO used here and 
thus it often dominated the headspace of vapour chambers used in this study. 
It is suggested from findings presented here that reduced anti-biofilm effects 
exhibited in the vapour chamber containing a greater volume of EO is due to 
this dominance of eucalyptol in the headspace. It is suggested that eucalyptol 
may be having an antagonistic effect and inhibiting cinnamaldehyde from 
exerting its known antimicrobial effects. MIC and MBC testing of components 
alone and in combination in this chapter suggested that this is true, although 
further investigations are needed to evaluate the effects of other minor 
compounds found in cinnamon EO.  
This study was the first to evaluate the headspace of vapour chambers used 
to treat biofilms with EO vapour and puts forth a novel method of in situ 
sampling to assess vapour composition using SIFT-MS. This method is of 
particular importance as this chapter has highlighted the importance of using 
a method that is capable of real time analysis in circumstances where vapour 
 157 
composition is constantly evolving and where this varying composition of 
vapour is critical in its effects. The findings in this chapter suggest that use of 
pure components from EOs as antimicrobials may be beneficial, due to the 
potential interference from other minor compounds and the risk of antagonistic 
behaviour when part of the whole EO. However, if whole EO is to be used as 
an antimicrobial, in either liquid or vapour applications, then analysis must be 
carried out on the phase that it is intended to be used in, to fully understand 
which constituents are responsible.  
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CHAPTER 7 
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7 DISINFECTANT POTENTIAL OF CINNAMON BARK 
ESSENTIAL OIL  
 
7.1 Introduction 
EOs as antimicrobials, and their potential applications, are well described in 
the literature and supported thus far in this thesis. Chapter 4 identified the 
broad spectrum activity of several EOs and chapters 4-6 highlighted the 
antimicrobial activity of cinnamon EO against P. aeruginosa, and its ability to 
cause significant reduction in bacterial viability at low concentrations following 
short contact times. The potential real-world application of EOs, and their use 
as antimicrobials, was also briefly discussed in Chapter 1. Many of the studies 
that look at EOs as antimicrobials have looked at their potential application in 
the food industry (Chouhan et al. 2017). EOs have been used to delay spoilage 
and improve aromatic qualities in vacuum packed meat and fish (Burt 2004); 
in antimicrobial packaging films or coatings to reduce surface molds and 
bacterial contamination (Rodríguez et al. 2007, Gómez-Estaca et al. 2010, 
Sanla-Ead et al. 2011, Avila-Sosa et al. 2012, Alvarez et al. 2014, 
Tongnuanchan and Benjakul 2014); applied to baked goods (Ju et al. 2018); 
and in aquaculture to treat fresh water fish (Kačániová et al. 2017). EO 
application has also been suggested in the cosmetic industry in mouth rinses 
to protect against oral bacteria (Moon et al. 2011); as a topical antimicrobial 
(May et al. 2000); and as wound disinfectants (Warnke et al. 2009). EOs have 
also been suggested for use as disinfectants  (Laird et al. 2012). A disinfectant 
is an antimicrobial capable of interrupting an infection on contaminated 
inanimate non-living objects (Presterl et al. 2019). In developing a new 
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disinfectant the British standards (BS EN) employ a 3 phase testing regimen 
which first uses quantitative suspension tests without regard to specific 
application (Gebel et al. 2013). This is followed by quantitative tests in both 
suspensions and simulated practical testing within the laboratory, in conditions 
representative of intended use; and finally field tests are carried out under 
practical conditions (Gebel et al. 2013). Under European standards, BS EN 
1040 covers phase 1, and BS EN 1276 and BS EN 13697 covers phase 2, for 
development of an antibacterial disinfectant intended for food, industrial, 
cosmetic and institutional areas (British Standards Institution 2009, 2015). 
Phase 3 standards are yet to be developed for disinfectant testing (Sandle 
2017). There are very few studies to date that investigate the potential of EOs 
under these European standards of disinfection. Yangui et al. (2009) studied 
the bactericidal and fungicidal activities of Pituranthos chloranthus EOs and to 
study their potential use as powerful and natural disinfectant; Bouaziz et al. 
(2009) looked at EOs from Salvia officinalis; Messager et al. (2005) assesses 
the antibacterial activity of tea tree oil and tea tree oil containing products; and 
Falcó et al. (2019) evaluated the sanitizing effects of 9 EOs. 
To my knowledge there is currently no research that uses the European 
standard BS EN 1276 to investigate cinnamon bark EO or its disinfection 
potential compliant with these standards. Therefore, the aim of this chapter is 
to evaluate cinnamon bark EO as a potential disinfectant against a panel of 
bacteria described in the BS EN 1276 standard. 
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7.1.1 Chapter progression 
The following flow diagram depicts a summary of the progression of this 
chapter. 
 
 
 
 
7.2 Methods 
7.2.1 Media and reagents  
 
7.2.1.1 Diluent 
Diluent comprised of 8.5 g L-1 sodium chloride and 1 g L-1 tryptone pancreatic 
digest of casein, at pH 7 and was sterilised by autoclave. 
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7.2.1.2 Disinfectant product 
Cinnamon bark EO was diluted in water containing 0.5% (v/v) Tween 80 to 
achieve a concentration of 2.5% (v/v). This solution was confirmed to stay in 
a stable homogenous suspension for the duration of >2 h. The concentration 
of EO was prepared at 1.25x final concentration to achieve 1x concentration 
in test method. Disinfectant product was used within 1 h.  
 
7.2.1.3 Interfering substance 
Bovine serum albumin (BSA; Sigma Aldrich, Dorset, UK) was used as an 
interfering substance as recommended by BS EN 1276. Testing was carried out 
under both clean conditions (0.3 g L-1 BSA) and dirty conditions (3 g L-1). BSA 
stock solutions were made up at 10x concentration, filter sterilised with 0.2 µM 
filter and kept at 4°C until needed. Stock solutions were used within 1 month.  
 
7.2.1.4 Neutraliser 
A neutralising solution was based on the aldehyde neutraliser composition 
recommended by BS EN 1276. Tween 80 (30 g L-1), lecithin (3 g L-1) and L-
histidine (1 g L-1) were added to phosphate buffer (34 g L-1 monopotassium 
phosphate, pH 7.2) and sterilised by autoclaving. Neutraliser controls were 
carried out to assess its toxicity against the test bacteria and its antimicrobial 
quenching activity. All neutraliser validation testing was carried out at 20°C. 
 
7.2.2 Test organisms and culture preparation 
Test organism used in this chapter included Staphylococcus aureus (NCTC 
12981), Pseudomonas aeruginosa (ATCC 15442), Escherichia coli (ATCC 
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10536) and Enterococcus hirae (ATCC 10541). Cultures were prepared as 
described in BS EN 1276:2009. 
 
7.2.2.1 Preparation of working culture 
Frozen stocks of organisms were revived by streaking onto TSA agar plates 
and incubating at 37°C for 24 h. After 24 h, a second subculture streak plate 
was prepared in the same way. These plates were the working cultures from 
which suspensions were made in broth.  
 
7.2.2.2 Test suspension 
For all organisms a test suspension was prepared by taking loopfuls of working 
culture (section 7.2.1.1) and placing in 10 mL of diluent, in 100 mL flasks. The 
flasks were vortexed for 1 min. This suspension was then adjusted using diluent 
and a spectrophotometer at OD620nm, until number of cells was approximately 1.5-
5 x 108 CFU mL-1. Suspensions were used within 2 h.  
 
7.2.2.3 Validation suspension 
 A validation suspension was prepared from the test suspension (section 
7.2.1.2). A 10-5 dilution of test suspension was diluted 1:3 in diluent to achieve 
approximately 3.0 x 10² to 1.6 x 10³ CFU mL-1. Suspensions were used within 
2 h. 
 
7.2.3 Neutraliser validation 
Two validation tests were performed in parallel to testing to ensure the 
neutraliser used did not exert any lethal effects on that bacteria tested, and to 
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ensure that it quenched the antimicrobial activity of the disinfectant after the 
required contact time. Validation was deemed successful if ≥50% of validation 
suspension bacteria were viable following testing, as described by BS EN 
1276. 
 
7.2.3.1 Neutraliser toxicity 
To ensure that the neutraliser had no bactericidal effects against test bacteria, 
8 mL of neutraliser was added to 1 mL of water and 1 mL of validation 
suspension. After 5 minutes of incubation, the solution was serially diluted in 
sterile PBS and CFU mL-1 was calculated by spiral plating onto TSA and 
incubating for 24 h at 37°C. Toxicity testing was carried out alongside each 
replicate of suspension testing (N=3).  
 
7.2.3.2 Neutraliser quenching 
To ensure that the neutraliser sufficiently quenched the disinfectant product 1 
mL water was mixed with 1 mL diluent, followed by the addition of 8 mL 
disinfectant product. After 1 min of incubation, 1 mL of solution was removed 
and added to 8 mL of neutraliser. Following a 5 min incubation period, 1 mL of 
validation suspension was added, and the solution was left for 30 min, followed 
by enumeration by spiral plating onto TSA and incubating for 24 h at 37°C. 
Quenching testing was carried out alongside each replicate of suspension 
testing (N=3). 
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7.2.4 Suspension testing 
Suspension testing was carried out under both clean and dirty conditions. One 
millilitre of interfering substance was mixed with 1 mL of test suspension. 
Following a 2 min incubation, 8 mL of disinfectant product (2.5% v/v) was 
added, and mixture was shaken. Final concentration of disinfectant was 2% 
(v/v). After 5 min of contact, 1 mL was removed and transferred to a tube 
containing 8 mL of neutralizer and 1 mL of water. After 5 min, the solution was 
serially diluted, and bacteria were enumerated on TSA using a spiral plater. 
Plates were incubated for 24 h at 37°C. As described by BS EN 1276, a 
disinfectant is deemed successful when a 5 log reduction is achieved within 5 
min of contact time.  
A control test was carried out at the same time as suspension testing using 
validation suspension, and water in place of disinfectant product, to verify that 
suspension testing had no lethal effects on the bacteria. The control was 
deemed successful if ≥50% of validation suspension bacteria were viable 
following testing, as described by BS EN 1276. Each experiment had three 
replicates and were carried out independently in triplicate.  
 
7.2.5 Extended contact suspension testing 
Extended contact time testing was carried out for Gram-positive bacteria; 
Staphylococcus aureus (NCTC 12981), and Enterococcus hirae (ATCC 
10541). The method was carried out as described in section 7.2.4, however, 
disinfectant product was left for a total of 15 min contact time before solution 
was neutralised. Each experiment had three replicates and were carried out 
independently in triplicate. 
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7.2.6 Data analysis  
Two-way ANOVA with Dunnett’s multiple comparisons were used to assess 
significant differences in validation testing, whilst Two-way ANOVA was used 
to evaluate significant differences in suspension testing.  
 
7.3 Results 
7.3.1 Neutraliser toxicity 
Results from validation of neutraliser toxicity are shown in Table 7.1. The 
neutraliser did not reduce the bacteria tested significantly (P>0.05) and did not 
reduce the validation suspension by more than 50%, confirming that the 
neutraliser was not toxic.  
 
7.3.2 Neutraliser quenching 
Results from validation of neutraliser quenching are shown in Table 7.2. The 
neutraliser did not significantly reduce the bacteria tested (P>0.05), in either 
clean or dirty conditions. The neutraliser did not reduce organisms more than 
50%, confirming that the neutraliser was able to efficiently quench the effects 
of cinnamon bark EO.   
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Table 7.1 – Neutraliser Toxicity Testing 
Results of neutraliser toxicity validation testing showing difference between 
original validation suspension CFU mL-1 and viable bacteria following 5 min 
contact with neutraliser. N=3; values expressed as average difference in log10 
CFU mL-1 of viable bacteria ± standard error. 
Bacteria 
Difference in log10 
CFU mL-1 
Pass/Faila 
S. aureus -0.31 ±0.42 Pass 
E. hirae -0.25 ±0.45 Pass 
E. coli -0.62 ±0.45 Pass 
P. aeruginosa -0.34 ±0.43 Pass 
a Pass defined as no more than 50% log reduction when compared to validation 
suspension (CFU mL-1) as described by BS EN 1276. 
Table 7.2 – Neutraliser Quenching Testing 
Results of neutraliser quenching validation testing, in both clean and dirty 
conditions, showing difference between original validation suspension CFU mL-1 
and viable bacteria following 30 min contact with neutralised disinfectant. N=3; 
values expressed as average difference in log10 CFU mL-1 of tested bacteria ± 
standard error. 
Bacteria 
Clean Dirty 
Difference in 
log10 CFU 
mL-1 
Pass/Faila 
Difference 
in log10 
CFU mL-1 
Pass/Faila 
S. aureus -0.65 ±0.15 Pass -0.21 ±0.52 Pass 
E. hirae -0.55 ±0.23 Pass -0.55 ±0.16 Pass 
E. coli -1.10 ±0.03 Pass -1.00 ±0.17 Pass 
P. aeruginosa -0.33 ±0.33 Pass -0.45 ±0.31 Pass 
a Pass defined as no more than 50% log reduction when compared to validation 
suspension (CFU mL-1) as described by BS EN 1276. 
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7.3.3 Suspension testing 
Results from suspension testing of cinnamon bark EO (2% v/v) are shown in 
Figure 7.1. In both clean and dirty conditions, the control suspension was not 
significantly reduced (P>0.05), and bacterial viability was greater than 50% of 
the original validation suspension, confirming that the test method did not have 
any lethal effects against the bacteria tested. Cinnamon bark EO (2% v/v) was 
successful in significantly reducing E. coli (P<0.01) and P. aeruginosa 
(P<0.05), in both clean and dirty conditions, by >5 log CFU mL-1. E. coli 
showed a log reduction of 7.06 in both clean and dirty conditions, whilst P. 
aeruginosa showed a 7.16 log reduction in both conditions. Although 
cinnamon EO was able to significantly reduce S. aureus (P<0.001) and E. 
hirae (P<0.05), it was unable to cause a greater than 5 log reduction for either 
of these organisms within 5 min. In clean conditions S. aureus was reduced 
2.23 log and E. hirae was reduced 0.71 log, in dirty conditions S. aureus was 
reduced 1.02 log and E. hirae was reduced 0.46 log. BSA did not have any 
significant effect on antimicrobial activity (P>0.05), for any of the testing 
conditions.  
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7.3.4 Extended contact suspension testing 
Results from suspension testing of cinnamon bark EO (2% v/v) are shown in 
Figure 7.2. In both clean and dirty conditions, the control did not significantly 
reduce the validation suspension (P>0.05), nor did it reduce bacteria by 
greater than 50%.  
Although cinnamon EO was able to significantly reduce S. aureus (P<0.001) 
and E. hirae (P<0.05), it was unable to cause a greater than 5 log reduction 
for either of these organisms within 15 min. In clean conditions S. aureus was 
reduced 1.37 log and E. hirae was reduced 0.63 log, in dirty conditions S. 
aureus was reduced 1.02 log and E. hirae was reduced 0.49 log. BSA did not 
have any significant effect on antimicrobial activity (P>0.05), for any of the 
testing conditions. 
.
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7.4 Discussion 
The potential real world application of EOs have been discussed previously in 
this chapter introduction, and surface disinfection has been recognised as a 
promising application. Previous chapters thus far have investigated the 
antimicrobial activity of cinnamon bark EO, in liquid state, against a range of 
planktonic bacteria and P. aeruginosa biofilms. Cinnamon EO exhibited 
success against a broad range of both Gram-positive and Gram-negative 
organisms, effectively inhibiting and killing at low concentrations, and reducing 
bacteria by >5 log CFU mL-1. However, for an antimicrobial to be considered 
for disinfection, it must comply with disinfection standards. Thus, this chapter 
aimed to investigate cinnamon bark EO as a potential disinfectant using the 
BS EN 1276 standards of disinfection (British Standards Institution 2009). 
Cinnamon EO has shown broad spectrum activity against both Gram-negative 
and Gram-positive bacteria (chapter 4) when using preliminary disc diffusion 
assays. Drawing from previous chapter investigations, cinnamon EO was 
tested in this chapter at a concentration of 2% (v/v), a concentration that was 
proven to be successful against both planktonic bacteria and biofilms (chapter 
4-6). At this concentration, cinnamon EO was able to reduce P. aeruginosa 
broth cultures in time kill assays by >5 log within 2 min (chapter 4). BS EN 
1276 stipulates that a successful disinfectant must achieve a 5 log reduction 
in bacterial load within 5 min, however, the panel of bacteria that are described 
includes both Gram-negative and Gram-positive bacteria.  
BS EN 1276 also requires the use of interfering substances relative to the 
intended use of the disinfectant. As the proposed usage of cinnamon EO in 
this chapter was as a general purpose disinfectant to be used in food, 
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industrial, cosmetic and institutional areas, BSA was used as an interfering 
substance, as recommended by BS EN 1276. The addition of BSA provides a 
better representation of disinfection in the real world, as organic matter is often 
found as an environmental contaminant, and evaluating cleaning agents in its 
presence mimics practical applications (Vohra and Poxton 2011). Studies 
have also shown that the presence of BSA quenched the activity of 
antimicrobials (Bessems 1998) and offered bacteria a form of protection during 
disinfectant challenges (Simões et al. 2006). In contrast to this, the present 
study found that the presence of BSA, at both low (0.3 g L-1) and high 
concentrations (3.0 g L-1), did not have a significant effect (P>0.05) on the 
antimicrobial activity of cinnamon EO against any of the bacteria tested.  
Cinnamon EO (2% v/v) successfully reduced P. aeruginosa and E. coli by 5 
log, within 5 min contact time, however EO at this concentration was unable 
to produce the same effects against S. aureus and E. hirae within 5 min.  
 
Although many studies report that EOs are more effective against Gram-
positive bacteria (Zaika 1988, Bisignano et al. 2001, Nazzaro et al. 2013, 
Chouhan et al. 2017, Man et al. 2019), conversely, several studies have 
reported that EOs have superior efficacy against Gram-negative bacteria  
(Prabuseenivasan et al. 2006, Lodhia et al. 2009, Lopez-Romero et al. 2015). 
Furthermore, a comparable finding to those presented in this study was shown 
by Mayaud et al. (2008), who found that Cinnamomum verum EO successfully 
reduced Gram-negative bacteria, but when used to challenge Gram-positive 
bacteria, higher concentrations and longer contact times were required. 
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Yangui et al. (2009) also found that higher concentrations of orange EOs were 
required to achieve 5 log reductions in Gram-positive bacteria.  
The reduced efficacy of cinnamon EO against Gram-positive bacteria, 
compared to that of Gram-negative bacteria, may be due to the structure of 
Gram-positive bacteria. Whilst Gram-negative bacteria may possess an 
exterior lipopolysaccharide membrane, its adjacent peptidoglycan cell wall is 
thin, only 7-8 nm, and lacks strength and rigidity (Shrivastava et al. 2007). In 
contrast to this, Gram-positive bacteria have a much thicker peptidoglycan cell 
wall which can be up to 80 nm thick, and has a 3-dimensional rigid structure 
(Shrivastava et al. 2007). It has been previously discussed (chapter 4) that the 
mode of action of cinnamon EO may lie in its hydrophobic characteristic. The 
outer membrane possessed by Gram-negative bacteria is made up of 
phospholipids, lipopolysaccharides and various regulatory channels (Nazzaro 
et al. 2013), a feature which usually negates the passage of hydrophobic 
substances due to the presence of hydrophilic porin channels (Lopez-Romero 
et al. 2015). However, in the present study, Gram-negative bacteria were not 
less susceptible to cinnamon EO. A possible explanation for the contradictory 
reports of efficacy of oils against Gram-positive and Gram-negative bacteria 
may be the antimicrobial constituents of the EO used. A feature of cinnamon 
bark EO is that its main constituent is cinnamaldehyde, as reported previously 
(chapter 4). Aldehydes are reported to exert bactericidal effects by disrupting 
lipoproteins in the outer membrane (Remmal et al. 1993), and penetrating the 
outer membrane leading to cell content disruption and leakage (Walsh et al. 
1999), which is a likely explanation for the effects seen in this study. 
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To assess if contact time influenced efficacy, further investigations were 
carried out to challenge the Gram-positive bacteria with cinnamon EO for an 
extended contact time of 15 min. Despite this increased contact period, 
cinnamon EO was unsuccessful in reducing both S. aureus and E. hirae by >5 
log CFU mL-1. A possible explanation for this decreased antimicrobial activity 
could be the presence of Tween 80 in the disinfectant product. Tween 80 is a 
surfactant and was used in this study to produce an oil in water emulsion which 
stayed homogenous throughout testing. It is reported that this emulsion of EO 
and surfactant could be an antagonistic combination, as was seen by Ziani et 
al. (2011), who found decreased antimicrobial activity of tea tree oil when 
emulsified with Tween 80. Remmal et al. (1993) found that when using Tween 
80 as a dispersal agent, antimicrobial activity of EOs was significantly reduced. 
However, in contrast to this, Lu et al. (2018)  reports that surfactants improve 
the antimicrobial activity of EOs by increasing surface area, improving cell 
membrane interactions, promoting targeted release, and providing 
electrostatic interactions with the bacterial cell wall. The contradictory 
evidence discussed here highlights the need for further investigations 
regarding the interactions between EOs, and the detergents used with them, 
to evaluate whether they are synergistic, antagonistic or additive.  
In conclusion, this chapter aimed to investigate cinnamon bark EO as a 
potential disinfectant and evaluate its compliance with European standard BS 
EN 1276. To my knowledge, this study was the first to investigate cinnamon 
bark EO as a disinfectant and evaluate its compliance with recognised 
disinfectant standards. These standards required a disinfectant at this stage 
of testing (phase 2, step 1) to achieve a 5 log reduction within 5 min of contact. 
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Cinnamon EO was compliant with this standard against Gram-negative 
bacteria, though was unable to sufficiently reduce S. aureus and E. hirae after 
5 min contact. Furthermore, an extended contact time of 15 min did not 
improve the efficacy of the EO against Gram-positive organisms. Although this 
may not be encouraging for the potential of cinnamon EO to be a stand-alone 
disinfectant, the results reported here have highlighted the potential for 
cinnamon EO to contribute to the cleaning regimes already used and that it 
could prove to be an effective additional constituent in future disinfectants. 
Within the methods used here, several potential reasons for reduced activity 
have been identified, including the possible interference from surfactants 
within emulsions used to produce homogenous disinfectant products 
containing EO. It is suggested that further investigations are made to evaluate 
disinfectant formulations which incorporate EOs, and ensure that the full 
antimicrobial potential of these oils are reached without hindrance from 
components which constitute the disinfectant. This study has provided a 
preliminary investigation into the use of cinnamon EO as a disinfectant, 
identifying its disinfectant activity against some but not all organisms, and 
demonstrating that further testing is needed to include extended contact times.  
 
 
 179 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 8 
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8 DISCUSSION AND FURTHER WORK 
The main aim of this research was to contribute to the search for novel 
antimicrobials, in response to the antimicrobial resistance (AMR) crisis being 
faced on a global scale. Essential oils (EOs) are an underutilised natural 
commodity, with recognised antimicrobial activity, and due to the vast selection 
of these plant extracts, many of them remain under exploited. The data 
presented in this thesis has further contributed to the current literature that 
exists on EOs, and has broadened the knowledge surrounding antimicrobial 
efficacy, potential applications and practical methods to utilise when 
evaluating EOs. The research and methods presented in this thesis have a 
wide spreading impact on many real life applications, for example: contributing 
to current cleaning regimes; potentially improving the efficacy of existing 
antimicrobials; and improving the methods utilised to assess essential oil liquid 
and vapour, and other antimicrobials. The work presented in this thesis 
provides a sound basis for further work and continuation of research into EOs 
as antimicrobials. Further work could be carried out to evaluate the potential 
of EOs to behave synergistically when in combination with antibiotics; to fully 
explore their mode of action and exploit these findings to target problematic 
bacteria; to investigate their toxicity in humans and include them in models of 
biofilm growth that better mimic natural and human environments, and how the 
surface on which bacteria grow impacts their tolerance to antimicrobials; and 
to further utilise the pure compounds which compose EOs and how these 
isolated constituents can be utilised.  
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 EOs are extensively used across the globe with a multitude of uses, as 
discussed elsewhere. At present, there are no legislations which require EO 
manufacturers or distributers to confirm the purity and origin of essential oils, 
if they are not intended for cosmetics, food or the animal nutrition market 
(Barbieri and Borsotto 2018). This thesis has highlighted the critical 
importance of analysing EOs before evaluation of their antimicrobial effects. 
As was demonstrated here, EOs from the same plant species, but obtained 
from different plant parts, can have very different compositions. It is clear from 
the findings of chapter 4 and 7 that analysing the composition of EOs is 
imperative for oils intended for antimicrobial or bioactive applications. Not only 
do the composition of EOs in liquid state vary from batch to batch due to a 
variety of factors, but the composition of the liquid state EO is not always 
reflected when the EO is in its vapour state. Composition of EOs can also have 
a significant effect on the antimicrobial efficacy of the oil. Data presented in 
chapter 7 found that the cinnamon EO constituent eucalyptol seemed to have 
an antagonistic effect on the activity of cinnamaldehyde, the suggested 
dominant antimicrobial constituent of cinnamon EO. These findings suggest 
that although the use of whole EO is often successful, some of the minor 
components may inhibit the antimicrobial activity of other constituents. 
Commercially, the intricate and complex composition of natural EOs is often 
challenging to regulate and difficult to synthetically reproduce. Preliminary 
results in this thesis indicates that cinnamaldehyde had a greater antimicrobial 
effect than cinnamon EO. Therefore, it is suggested that further work be 
carried out using isolated pure compounds from cinnamon EO, i.e. 
cinnamaldehyde, to evaluate its antimicrobial efficacy alone.  
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The novel data presented in chapter 4 support the literature which indicate the 
mode of action of cinnamon EO against bacteria, and that it is attributed to 
membrane permeation. The research presented here suggests the ability of 
cinnamon EO to penetrate the exterior barriers of bacteria, thus causing 
disruptions in the membrane from which cell contents could leak. However, 
this could also work to the advantage of many failing antimicrobials, which are 
unable to penetrate these resistant bacteria, allowing a route of entry into the 
cell and enabling them to exert their effects. Many studies have already looked 
at interactions between essential oils and current antimicrobials, and found 
that EOs have a synergistic effect when combined with antibiotics (Langeveld 
et al. 2014). Magi et al. (2015) found that when in combination with carvacrol, 
a component of essential oils, the MIC of erythromycin against erythromycin 
resistant strains of Streptococci was reduced by up to 2048-fold. Nafis et al. 
(2019) found that essential oil from Cannabis sativa decreased the MIC of 
ciprofloxacin by 2- to 64-fold and decreased the MIC of fluconazole by 16-fold 
when used in combination against Candida spp. Whilst synergy studies of 
Cinnamomum species have been published (Yang et al. 2017, El Atki et al. 
2019), studies using Cinnamomum zeylanicum are very limited (Utchariyakiat 
et al. 2016). The promising results shown in these studies, combined with 
those reported in this thesis, endorses the idea of using EOs to support the 
current antimicrobial repertoire and combat AMR. The dramatic decrease in 
production of new antibiotics warrants the enhancement of existing antibiotics 
(Rogers et al. 2012). Therefore, further work is suggested to more extensively 
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evaluate the mode of action of cinnamon EO and investigate its potential to 
increase the efficacy of existing antimicrobials.  
 
The majority of persistent and untreatable infections are due to biofilm-forming 
bacteria. One of the issues identified with testing for novel antimicrobials is the 
failure to include bacteria in their biofilm state during testing (Cookson 2005). 
Results from chapter 5 have shown liquid applications of cinnamon EO to be 
highly effective against P. aeruginosa biofilms, which are usually known to be 
robust and impenetrable to many antimicrobials. P. aeruginosa biofilms are 
commonly implicated in persistent contamination sites associated with the 
clinical environment. This organism is known to be found in many places that 
common protocols either do not eradicate, or cannot reach, and thus it is 
proposed that cinnamon EO could be used as an antimicrobial in many of the 
sites that act as a reservoir for P. aeruginosa biofilms. Hard to reach reservoirs 
of bacteria could be combatted by employing EOs in their vapour form to 
maintain better contact with inaccessible places. The surface on which biofilms 
are found is another important factor when considering anti-biofilm effects. 
Chapter 5 observed differences in efficacy when biofilms were grown on 
different surfaces, highlighting the importance of understanding the underlying 
mechanics of biofilm formation and how this might affect treatment of these 
organisms in situ. This difference in efficacy was also observed when treating 
biofilms with EO vapour in chapter 6, where biofilms grown on stainless steel 
were less susceptible than those grown on polycarbonate plastic. This data 
further highlights the importance of surfaces when considering biofilm models 
for antimicrobial testing. Although polycarbonate plastic and stainless steel are 
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surface materials commonly found in a wide range of locations, including 
clinical environments, further work is suggested to look more extensively at a 
wider range of surface materials and evaluate the impact they have on biofilm 
growth and anti-biofilm efficacy.  
 
EOs are extracted from plants, usually via steam distillation, and exist in a 
liquid form. However, the constituents of these liquids are highly volatile and 
thus, EOs are often utilised in their gaseous state. Novel experiments 
presented in chapter 6 demonstrated that cinnamon EO vapour was capable 
of reducing preformed mature biofilms by >5 log CFU mL-1 at concentrations 
as low as 0.2 µL cm-3. Although it is acknowledged that further toxicity testing 
is paramount to the use of EOs in human applications, the efficacy of 
cinnamon EO vapour against P. aeruginosa biofilms shown here is important. 
P. aeruginosa is implicated in many human diseases, especially recurrent 
infections arising in cystic fibrosis (CF) patients, which are often caused by 
biofilm-forming strains (Høiby et al. 2010). Treatment by inhalation of EOs has 
been discussed in the literature (Blake and Raissy 2018) and cinnamon bark 
EO has been suggested for treatment of respiratory pathogens (Singh et al. 
1995, Inouye et al. 2001). However, to my knowledge, research presented in 
this thesis was the first of its kind to assess the efficacy of cinnamon EO vapour 
against a shear-flow model grown biofilm which could potentially be translated 
to those biofilms growing within the human respiratory system. It is an 
important consideration, when developing methods that are used to 
investigate biofilms that an appropriate model of growth is used which reflects 
the natural existence of bacteria. Sriramulu et al. (2005) developed a novel 
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biofilm model which mimics biofilm formation within a CF lung, and Crabbé et 
al. (2017) investigated the efficacy of antibiotics against biofilms growing in a 
3-dimensional lung epithelia model. Thus, if cinnamon EO is to be considered 
as a potential treatment for respiratory infections, it is suggested that further 
work be carried out to not only examine the toxicity of the EO but also its 
efficacy in biofilm models which better mimic the human respiratory 
environment.   
 
Potential applications of EOs include that of disinfectant production. Data 
presented in this thesis has shown cinnamon bark EO to be an effective 
antimicrobial agent capable of rapid killing at low concentrations. Chapter 8 
demonstrated that cinnamon bark EO was successful at reducing the viability 
of Gram-negative bacteria within 5 min of contact. However, the EO at this 
concentration was not efficient at eliminating Gram-positive bacteria, despite 
testing with extended contact times of 15 min. However, not only did cinnamon 
EO exceed the expected levels of disinfectant action against Gram-negative 
bacteria, this thesis also showed that over a 24 h period, cinnamon EO 
possessed the ability to inhibit and kill Gram-positive bacteria at very low 
concentrations. Furthermore, the efficacy of cinnamon EO versus biofilm-state 
bacteria is clear, and it has demonstrated strong anti-biofilm activities. 
Therefore, there is a need to investigate the disinfectant potential of this oil 
further, particularly in the area of surface disinfection and with a wide panel of 
bacteria associated with food, clinical and non-clinical environments. 
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Methods used in this thesis, such as the development of the novel vapour 
chamber and the use of SIFT-MS instrumentation, could be applied to many 
different in vitro investigations, and should not be limited to work investigating 
EOs. The chamber developed in this thesis can provide the means to carrying 
out a plethora of biofilm treatments using any antimicrobial agent that exists in 
a gaseous state. It facilitates the inclusion of biofilms grown using the CBR, an 
important model of biofilm growth when considering anti-biofilm testing. In 
combination with vapour analysis methods such as SIFT-MS, it enables real-
time analysis of the headspace within the chamber, and potential elucidation 
of the mechanisms of action of antimicrobial vapours.   
 
Overall, this thesis has demonstrated the strong antimicrobial efficacy of 
cinnamon EO and warrants the continuation of investigations in vitro, to 
evaluate its effects against a broader spectrum of biofilm forming bacteria. Not 
only does this thesis highlight the importance of cinnamon EO, but it also 
strengthens the rationale to continue testing other underexploited oils that are 
yet to be investigated. Whilst more research is required before EOs are 
considered safe for clinical and in vivo use, the work presented here strongly 
suggests that work investigating the environmental application of EOs must 
continue. When considering AMR, the data reported in this thesis provide 
further evidence that EOs could prove to be a crucial addition in solutions to 
combat the antibiotic resistance crisis. It has addressed the need for research 
and development of novel antimicrobials, and end products that include 
cinnamon EO could help improve sanitation and hygiene.  
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